Original Article
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
N Engl J Med 1990; 322:494-500February 22, 1990
- Abstract
- Abstract
To assess the efficacy of surgical resection of brain metastases from extracranial primary cancer, we randomly assigned patients with a single brain metastasis to either surgical removal of the brain tumor followed by radiotherapy (surgical group) or needle biopsy and radiotherapy (radiation group). Forty-eight patients (25 in the surgical group and 23 in the radiation group) formed the study group; 6 other patients (11 percent) were excluded from the study because on biopsy their lesions proved to be either second primary tumors or inflammatory or infectious processes.
Recurrence at the site of the original metastasis was less frequent in the surgical group than in the radiation group (5 of 25 [20 percent] vs. 12 of 23 [52 percent]; P<0.02). The overall length of survival was significantly longer in the surgical group (median, 40 weeks vs. 15 weeks in the radiation group; P<0.01), and the patients treated with surgery remained functionally independent longer (median, 38 weeks vs. 8 weeks in the radiation group; P<0.005).
We conclude that patients with cancer and a single metastasis to the brain who receive treatment with surgical resection plus radiotherapy live longer, have fewer recurrences of cancer in the brain, and have a better quality of life than similar patients treated with radiotherapy alone. (N Engl J Med 1990; 322:494–500.)
Media in This Article
Figure 1
Length of Time to the Recurrence of the Original Brain Metastasis, According to Treatment Group.Figure 2
Actuarial Survival According to Treatment Group.Article Activity
- Article
METASTASES to the brain occur in 20 to 30 percent of patients with systemic cancer1 and are the most common type of intracranial tumor.2 , 3 The life expectancy of patients with brain metastases is short, and current treatment of such metastases is not very effective. Whole-brain radiation therapy is the current standard treatment, but patients treated with radiotherapy alone have a median length of survival of only three to six months.1 , 4 5 6 7 8 9 10 Despite occasional responses in individual patients, chemotherapy has not been shown to improve the survival of most patients with brain metastases.1 , 11 , 12 Approximately half of all metastases to the brain are single13 and therefore potentially treatable by surgical resection. The role of surgery in the management of brain metastases has been controversial, however, because of the complete absence of controlled clinical trials.
For over 60 years,14 , 15 surgery has occasionally been performed in patients with single brain metastases who otherwise have good prognoses. Uncontrolled retrospective studies of the effectiveness of surgical treatment have had conflicting results; several studies15 16 17 18 19 20 21 have shown substantial benefit from surgery, whereas others6 7 8 , 22 have found no benefit. Nonrandomized studies have been biased because the patients who received surgical treatment were those with minimal disease, whereas the patients treated with radiation alone were those with more extensive disease and poorer prognoses.
Uncontrolled studies have failed to determine what role, if any, surgery should have in the management of single brain metastases. In order to determine whether the surgical removal of single brain metastases resulted in improved survival and quality of life, we conducted a prospective, randomized trial comparing the effectiveness of surgery plus postoperative radiotherapy with that of radiotherapy alone.
Methods
Eligibility of Patients
Patients at least 18 years old who had radiographic evidence of a single metastasis to the brain were eligible for the study if they had documented systemic cancer (not originating in the central nervous system) that had been diagnosed by examination of tissue within five years of treatment of the brain metastasis. Patients also had to be capable of caring for themselves independently (as indicated by Karnofsky performance scores ≥70 percent23). Patients were excluded if they had brain lesions that were not potentially surgically resectable; evidence of leptomeningeal metastases; a history of cranial radiotherapy; a need for immediate treatment to prevent acute neurologic deterioration; or certain radiosensitive primary tumors (small-cell lung cancer, germ-cell tumors, lymphoma, leukemia, and multiple myeloma).
Study Design
The study was a randomized, prospective trial with two treatment groups. The experimental protocol was approved by the institutional review board of the University of Kentucky Medical Center, and written informed consent was obtained from each patient before his or her entry into the study. Before randomization, all patients underwent both computerized tomography (CT scanning) and magnetic resonance imaging of the head to rule out multiple lesions. In addition, the extent of disease was evaluated in all patients; this evaluation consisted of a chest x-ray film, hematologic and chemical profiles, CT scanning of the abdomen or a radionuclide liver—spleen scan and bone scan, as clinically indicated, and other studies considered appropriate to each patient's primary tumor. At the time of the diagnosis of brain metastasis, all patients were given dexamethasone (4 mg every six hours), which was continued throughout the course of radiation therapy and then discontinued. Patients who could not tolerate the cessation of corticosteroids were maintained at the lowest dose possible. Before randomization, the patients were stratified according to the location of the tumor (supratentorial or infratentorial), the extent of disease (brain metastasis, brain metastasis plus cancer in the primary site, or brain metastasis plus cancer in the primary site and at least one additional site), and the type of primary tumor. Computer-generated random numbers were then used to assign patients to one of two treatment groups (one group received surgery plus radiotherapy, and another received radiotherapy alone).
For patients in the surgical group, surgical treatment was undertaken within 72 hours of entry into the study. All patients underwent craniotomy, and the goal of surgery in all cases was the total removal of the metastasis. All patients underwent contrast CT scanning between postoperative days 2 and 5 to determine whether the surgical removal of the tumor was complete.24 Within 14 days after surgery, the patients began receiving 36 Gy (3600 rad) of whole-brain radiation therapy, delivered through two lateral ports covering the brain and meninges to the foramen magnum. A dose fraction of 3 Gy of cobalt-60 per day was given at a rate of 1 to 2 Gy per minute. A total of 12 dose fractions was given on weekdays.
In the radiation group, patients with supratentorial lesions who were randomly assigned to treatment with radiation alone underwent stereotaxic needle biopsies of the suspected metastasis within 72 hours after entering the study. Patients with infratentorial lesions did not undergo biopsy because of the increased risk posed by biopsy in that area. Within 48 hours of biopsy or study entry (in patients who did not undergo biopsy), patients received radiotherapy according to the same treatment schedule and dosage used for the patients in the surgical group.
After treatment of the brain metastasis, each patient continued to receive appropriate treatment, if needed, for the primary tumor.
Evaluation and Criteria for Response
After the treatment of the brain metastasis, patients were evaluated every three months by means of neurologic examinations and magnetic resonance imaging or contrast CT scanning. If a recurrence was detected and the patient's condition warranted it, further treatment — surgery, repeat radiotherapy, or both — was provided. The nature of the additional treatment depended on the patient's condition.
To compare the efficacy of the two treatments, we evaluated changes in functional independence as indicated by Karnofsky scores, radiographic evidence of changes in tumor size or recurrence of the brain metastasis, the length of time to recurrence, the length of survival, and the causes of death in the two groups. Clinical improvement after treatment was measured by changes in Karnofsky performance scores. Patients who had Karnofsky scores lower than their pretreatment scores 30 days after surgery were considered to have surgical morbidity. The quality of life after the treatment of the brain metastasis was measured by the length of time Karnofsky scores remained ≥70 percent. (A patient with a score of 70 percent can care for himself or herself but is unable to work or maintain a normal level of activity.) The recurrence of brain metastases was identified by CT scanning or magnetic resonance imaging, and the development of leptomeningeal metastases was identified by examination of the cerebrospinal fluid. A recurrence of the original brain metastasis was defined as the reappearance of a metastasis in exactly the same site as the first metastasis. The radiation group included some patients whose original brain tumors never completely disappeared; in those patients, recurrence was defined as an enlargement of the original brain lesion after treatment. The length of time to the recurrence of the original brain metastasis was calculated from the date of the first treatment of the metastasis to the date when a recurrence in the same site was verified by CT scanning or magnetic resonance imaging. A distant recurrence in the brain was defined as the appearance of a new brain metastasis at a site different from that of the original metastasis. The length of survival was calculated from the first day of treatment of the brain metastasis to death or the last follow-up evaluation.
The cause of death was determined for all patients who died; patients were considered to have died of neurologic causes if they had stable systemic disease and progressive neurologic dysfunction. Patients with severe neurologic disability who died from intercurrent illness (e.g., sepsis) were also included among those with neurologic causes of death, as were patients with both rapidly progressive systemic disease and advancing neurologic dysfunction. Even if these patients had not had progressive systemic disease, they would still have died of neurologic causes and thus represented failures of treatment. The systemic cancer was considered the only cause of death if patients with neurologic improvement or stabilization had fatal infections, hemorrhages, or failure of vital organ systems other than the brain. Deaths within 30 days of surgery were considered operative deaths.
Statistical Analysis
The results obtained in a nonrandomized, retrospective comparison of surgery plus postoperative radiation with radiation alone20 were used to estimate the sample size needed for our study. In the earlier study, the median length of survival of patients in the surgical group was 19 months, whereas the median length of survival of patients in the radiation group was 9 months; thus, the ratio of the medians was 19:9, or 2.11. Assuming exponential survival, we estimated that, for a randomized trial, a sample of approximately 24 patients in each group would be required for the study to have a power of 80 percent to demonstrate a significant difference in the overall length of survival at a significance level of P<0.05.25
Survival curves were drawn by the Kaplan–Meier product-limit method.26 When the survival curves were based on neurologic causes of death, deaths from other causes were treated as censored data. The log-rank test was applied to evaluate the differences between two or more survival curves. The effects of treatment and of the covariates for length of time to the recurrence of the original metastasis, actuarial survival, neurologic survival (i.e., survival when only deaths from neurologic causes were included), and the length of time Karnofsky scores remained at or above 70 percent were determined in a multivariate analysis with use of Cox regression analysis27 to determine the best subset of covariates associated with the various time-dependent end points through a stepwise proportional-hazards model. The covariates examined in all cases were the treatment group, age, sex, location of the brain metastasis, type of primary tumor (lung vs. all other types), extent of disease (disseminated vs. undisseminated), initial Karnofsky score (70 percent vs. ≥80 percent), and length of time between the diagnosis of the primary tumor and the development of the brain metastasis. Additional covariates were examined as appropriate (see Results). The chi-square test was used to determine the relation between two categorical variables, and Fisher's exact test was used when the cells in two-by-two contingency tables contained small numbers of patients. A two-tailed t-test was used to compare the means of continuous variables between the two treatment groups.
Results
Enrollment and Characteristics of Patients
Between October 1985 and December 1988, the option of participating in the study was offered to 56 consecutive patients who were referred to the Neurosurgery Division for the resection of suspected single brain metastases and who met the entry requirements. Only two patients declined to participate. Initially, 54 patients were entered in the study, but 6 of them (11 percent) proved on resection or biopsy not to have metastatic brain tumors. The six nonmetastatic brain lesions consisted of two glioblastomas, one low-grade astrocytoma, two abscesses, and one nonspecific inflammatory reaction. Our analyses of the outcome of the trial therefore included the remaining 48 patients, of whom 25 were randomly assigned to the surgical group and 23 to the radiation group. The base-line characteristics of the 48 patients are shown in Table 1Table 1
Patients' Characteristics.. There was no statistically significant difference in the distribution of variables between the two groups. In the surgical group, all the patients appeared to have had complete resections, as assessed by postoperative contrast CT scanning. No patients in either group were lost to follow-up. As of November 1, 1989, 43 of the 48 patients had died (21 of 25 in the surgical group and 22 of 23 in the radiation group), and the median follow-up for living patients was 71 weeks (range, 68 to 196). Because of the high percentage of deaths in both groups, the overall median follow-up was identical to the overall length of survival — 15 weeks in the radiation group and 40 weeks in the surgical group.Recurrence of Brain Metastasis
Surgical removal of the brain metastasis followed by postoperative radiotherapy resulted in substantially better local control of tumor in the brain than did radiotherapy alone. As shown in Table 2Table 2
Location of Recurrence of Metastatic Cancer in the Brain., the rate of recurrence at the site in the brain of the original metastasis (independent of distant brain metastases or leptomeningeal metastases) was significantly lower (P<0.02) in the surgical group (5 of 25 [20 percent]) than in the radiation group (12 of 23 [52 percent]). In addition, the length of time from treatment to the recurrence of the original brain metastasis (Fig. 1Figure 1Length of Time to the Recurrence of the Original Brain Metastasis, According to Treatment Group.) was significantly shorter for the patients treated with radiation alone (median, 21 weeks) than in the surgical group (median >59 weeks; P<0.0001; relative risk, 7.1; 95 percent confidence interval, 2.4 to 21.5). Multivariate analysis demonstrated that only surgical treatment of the brain metastasis (P<0.0001) and the absence of disseminated disease (P<0.0004) reduced the risk of a recurrence of the original brain metastasis. Surgical treatment had no effect on the subsequent development of metastases elsewhere in the brain. The occurrence of distant brain metastases or leptomeningeal metastases (independent of the recurrence of the original brain metastasis) was similar in both treatment groups (5 of 25 [20 percent] in the surgical group vs. 3 of 23 [13 percent] in the radiation group; P = 0.52).Survival
The patients treated with surgery plus radiation had a median length of survival of 40 weeks, whereas the patients treated with radiation alone had a median length of survival of only 15 weeks; actuarial survival (Fig. 2Figure 2
Actuarial Survival According to Treatment Group.) was significantly different in the two groups (P<0.01; relative risk of death, 2.2; 95 percent confidence interval, 1.2 to 4.1). Overall survival was still less than 10 percent in both treatment groups by week 90, however. Multivariate analysis showed that surgical treatment of the brain metastasis and a longer time between the diagnosis of the primary tumor and the development of the metastasis in the brain were associated with increased survival (P<0.04 for both variables), whereas the presence of disseminated disease and increasing age were associated with decreased survival (P<0.02 and P<0.01, respectively). When the treatments (surgery, radiation, or chemotherapy) given for the primary tumor after the treatment of the brain metastasis were entered as variables in the Cox analysis, none was found to be significantly associated with survival.When the length of time to death from neurologic causes in the two groups was compared (Fig. 3Figure 3
Neurologic Survival According to Treatment Group.), there was a significant difference between the survival curves, for which the median was 62 weeks in the surgical group and 26 weeks in the radiation group (P<0.0009; relative risk of death from neurologic causes, 5.2; 95 percent confidence interval, 1.8 to 15.2). Multivariate analysis showed that only surgical treatment of the brain metastasis (P<0.0008) was positively correlated with neurologic survival (i.e., with not dying from neurologic causes), whereas the presence of disseminated disease (P<0.002) was negatively correlated with survival. Additional variables representing the treatments given for the primary tumor after the development of the brain metastasis were not significantly associated with survival. When death from systemic causes ("systemic death") was used as the only survival end point in comparing survival times, there were no significant differences between the two treatment groups (P = 0.56); the median length of time to death from systemic causes was 54 weeks in the surgical group and 23 weeks in the radiation group. Of the patients who died, 15 of 21 (71 percent) in the surgical group and 11 of 22 (50 percent) in the radiation group died of systemic causes (P = 0.26).Less than half of all patients who had recurrences of brain metastases (of any type) received further treatment for their brain lesions. In the radiation group, 13 patients had recurrences, of whom 5 received additional treatment. Of these, one had surgery plus further radiation and lived an additional four weeks. Four patients received further radiotherapy only, with a median length of survival (from the start of the second course of radiation to death) of 10 weeks. In the surgical group, seven patients had recurrences; of those, four received additional treatment. One patient had a second operation (and no further radiotherapy) and lived an additional 28 weeks. Four patients received further radiotherapy only, with a median additional length of survival of 14 weeks.
Quality of Life
The patients in the surgical group maintained Karnofsky scores ≥70 percent (Fig. 4Figure 4
Duration of Functional Independence (Karnofsky Scores ≥70 Percent), According to Treatment Group.) much longer than the patients treated with radiation alone (median, 38 weeks vs. 8 weeks; P<0.005; relative risk that a Karnofsky score <70 percent would develop, 2.4; 95 percent confidence interval, 1.3 to 4.6). Multivariate analysis showed that only surgical treatment of the brain metastasis (P<0.007) was associated with a better quality of life, whereas increasing age (P<0.02) and the presence of disseminated disease (P<0.04) were associated with a poorer quality of life.Complications of Treatment
Operative mortality was 4 percent, and operative morbidity was 8 percent. In the radiation group, the 30-day mortality rate was 4 percent, and the 30-day morbidity rate was 17 percent. After stereotaxic biopsy, one patient had a hemiparesis that resolved within two weeks; no other complications were associated with the biopsies. The median length of the hospital stay for the admission during which the brain metastasis was treated was 27 days in the surgical group and 22 days in the radiation group (P = 0.48).
Discussion
The results of this prospective, randomized trial show that the surgical removal of single brain metastases followed by radiotherapy results in substantially longer survival and a better quality of life than treatment with radiotherapy alone. Surgical treatment permits better local control of the brain metastasis, which results in a subsequent reduction in morbidity and mortality from neurologic causes.
The large difference in overall survival in favor of surgical treatment resulted from a reduction in deaths due to the brain metastasis. In determining overall (actuarial) survival, we used both systemic and neurologic causes of death as end points. Surgery and radiotherapy treat only the brain metastasis, and deaths directly attributable to the failure of treatment for the brain metastasis are usually from neurologic causes. Therefore, using death from neurologic causes as the only survival end point is a more accurate way to determine the true effect of treatment for brain metastases. When neurologic survival in the two groups was compared, there was a large, statistically significant advantage associated with surgical treatment. When death from systemic causes was used as the only survival end point, the difference in survival between the two groups was not statistically significant. Therefore, the prevention of death from neurologic causes by the surgical treatment of the brain metastasis was the factor most responsible for the large difference in overall survival between the two groups.
There are several reasons for the failure of treatment of metastatic cancer in the brain. Treatment failures are of two types: recurrences at the original site and new metastases at sites in the brain other than the original one (distant metastases). The reasons for the two types of failure are probably different. Recurrence at the original site is almost certainly due to the failure of the initial treatment to eradicate the original metastasis totally. Recurrences at distant sites in the brain may result either from new metastases spreading to the brain after treatment for the original brain tumor has been completed or from the presence of additional (but undetected) brain metastases that were present but not destroyed by radiotherapy at the time the original brain metastasis was treated.
The radiation dose used in our study (36 Gy [3600 rad]) was chosen because that dose was near the high end of the range commonly used in the treatment of metastatic brain tumors. It is possible, but unlikely, that the use of a higher dose of radiation might have altered our results. However, large, multicenter trials conducted by the Radiation Therapy Oncology Group28 29 30 have failed to show any significant benefit from either higher radiation doses or different fractionation schemes in the treatment of brain metastases.
With any surgical procedure, operative mortality has to be weighed against any possible benefit from surgery. In earlier series of patients with single brain metastases who were treated with surgery, operative mortality rates were in the range of 10 to 34 percent.15 , 16 , 31 32 33 34 35 36 However, with improvements in surgical technique, the advent of CT scanning, and the use of corticosteroids, surgical mortality rates in most series reported during the past 10 years have been under 10 percent.19 , 20 , 37 , 38 The 4 percent rate in the present study was well within the acceptable range and was identical to the 30-day mortality rate in the radiation group. Therefore, there was no excess mortality due to surgery as compared with radiation alone.
An important finding was the high percentage of patients who proved after surgery or biopsy not to have metastatic brain tumors. All patients had tissue-proved primary tumors diagnosed before their entry into the study; 6 of the 54 patients (11 percent) did not have metastatic tumors despite having findings on CT scanning and magnetic resonance imaging that were consistent with single brain metastases. Although it has been standard practice to assume that patients with systemic cancer in whom intracranial lesions develop have brain metastases, there have been previous reports of false diagnosis rates as high as 50 percent with CT scanning.39 Given the relatively high rate of misdiagnosis of metastatic tumors on the basis of CT scanning, even if resection is not possible, a stereotaxic needle biopsy may still be worthwhile to confirm the diagnosis. This is especially true for patients with controlled systemic cancer whose survival is likely to depend on the treatment of the brain lesion. Half the patients in our study who proved not to have brain metastases had potentially reversible infectious or inflammatory conditions.
Although our study showed that surgery plus radiotherapy was superior to radiotherapy alone in the treatment of single brain metastases, radiotherapy alone remains the treatment of choice for most patients with brain metastases. This is so because only about 50 percent of brain metastases are single and therefore potentially resectable. Unfortunately, nearly half of patients with single metastases are not candidates for surgery because of the inaccessibility of the tumor, the presence of extensive systemic disease, or other factors.20 This leaves approximately 25 percent of all patients with brain metastases who would benefit from surgical resection; the rest should be treated with radiotherapy alone.
The patients with brain metastases who are most likely to benefit from surgical resection are those with a single surgically accessible lesion, either no remaining systemic disease (true solitary metastasis) or controlled systemic cancer limited to the primary site, and a life expectancy of at least two months. Because the median length of time that Karnofsky scores were maintained at pretreatment levels was about two months in the patients treated with radiotherapy alone, patients with life expectancies of less than two months should receive adequate palliation from radiation alone and are unlikely to gain any benefit from surgery.
Dr. Patchell is the recipient of a Clinical Oncology Career Development Award (87–102) from the American Cancer Society.
Source Information
From the Departments of Surgery (Neurosurgery Division) (R.A.P., P.A.T., J.W.W., R.J.D., B.Y.), Neurology (R.A.P., W.R.M.). Radiation Medicine (Y.M.), Statistics (R.J.K.), Pathology (W.R.M.), and Internal Medicine (J.S.M.), University of Kentucky Medical Center and Veterans Affairs Hospital, and Markey Cancer Center, Lexington. Address reprint requests to Dr. Patchell at the Neurosurgery Division, University of Kentucky Medical Center, Lexington, KY 40536–0084.
- References
References
1
Cairncross JG, Posner JB. The management of brain metastases. In: Walker MD, ed. Oncology of the nervous system. Vol. 12 of Cancer treatment and research. Boston: Martinus Nijhoff, 1983:341–77.
2
Walker
Web of Science | Medline3
Silverberg E, Lubera JA. Cancer statistics, 1988. CA 1988; 38:5–22.
4
Order
Web of Science | Medline5
Deeley
CrossRef | Web of Science | Medline6
Montana
CrossRef | Web of Science | Medline7
Berry
Medline8
Markesbery
Web of Science | Medline9
Cairncross
CrossRef | Web of Science | Medline10
Zimm
CrossRef | Web of Science | Medline11
Rosner
CrossRef | Medline12
Greig
CrossRef | Web of Science | Medline13
Delattre
Web of Science | Medline14
Grant
CrossRef | Web of Science | Medline15
Störtebecker
CrossRef | Web of Science | Medline16
Veith
CrossRef | Web of Science | Medline17
DiStefano
CrossRef | Web of Science | Medline18
Hendrickson
CrossRef | Web of Science | Medline19
Sundaresan
CrossRef | Web of Science | Medline20
Patchell
Web of Science | Medline21
Mandell
Web of Science | Medline22
Posner
Medline23
Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1949:191–205.
24
Cairncross
CrossRef | Web of Science | Medline25
George
CrossRef | Medline26
Kaplan
CrossRef | Web of Science27
Cox 28
Hendrickson
Web of Science | Medline29
Kurtz
CrossRef | Web of Science | Medline30
Gelber
CrossRef | Web of Science | Medline31
Richards
CrossRef | Medline32
Lang
Web of Science | Medline33
MacGee
CrossRef | Web of Science | Medline34
Ransohoff
Medline35
Black
CrossRef | Web of Science | Medline36
Winston
CrossRef | Web of Science | Medline37
White
Web of Science | Medline38
Kelly
CrossRef | Web of Science | Medline39
Todd
CrossRef | Web of Science | Medline
- Citing Articles (549)
Citing Articles
1
Simon S. Lo, Jeffrey D. Radawski, Alex Nelson, James W. Clarke, John M. McGregor, Nina A. Mayr, Robert Cavaliere, Jian Z. Wang, Zhibin Huang, John C. Grecula. (2012) Stereotactic radiosurgery with or without whole brain radiotherapy for patients with one to three melanoma brain metastases. Journal of Radiation Oncology
CrossRef2
D. Rades, J.D. Kueter, J. Gliemroth, T. Veninga, A. Pluemer, S.E. Schild. (2012) Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis. Strahlentherapie und Onkologie
CrossRef3
Raymond Sawaya, Rajesh K. Bindal, Frederick F. Lang, Dima Suki. 2012. Metastatic brain tumors. , 864-892.
CrossRef4
Nader Pouratian, Christopher P. Cifarelli, Mark E. Shaffrey, David Schiff. 2012. Clinical trials and chemotherapy. , 306-315.
CrossRef5
R. Soffietti, A. Ducati, R. Rudà. 2012. Brain metastases. , 747-755.
CrossRef6
Dawit G. Aregawi, Jonathan H. Sherman, David Schiff. 2012. Neurological complications of solid tumors. , 683-710.
CrossRef7
Ian F. Parney, Mitchel S. Berger. 2012. Principles of brain tumor surgery. , 187-213.
CrossRef8
Larry Junck. 2012. Clinical trials in neuro-oncology. , 417-434.
CrossRef9
Frank Attenello, Shaan M. Raza, Francesco Dimeco, Alessandro Olivi. 2012. Chemotherapy for brain tumors with polymer drug delivery. , 339-353.
CrossRef10
Shingo Noura, Masayuki Ohue, Tatsushi Shingai, Ayako Fujiwara, Shinya Imada, Toshinori Sueda, Terumasa Yamada, Yoshiyuki Fujiwara, Hiroaki Ohigashi, Masahiko Yano, Osamu Ishikawa. (2012) Brain metastasis from colorectal cancer: Prognostic factors and survival. Journal of Surgical Oncologyn/a-n/a
CrossRef11
Sebastià Sabater, Encarna Mur, Katrin Müller, Meritxell Arenas. (2012) Predicting compliance and survival in palliative whole-brain radiotherapy for brain metastases. Clinical and Translational Oncology 14:1, 43-49
CrossRef12
May N. Tsao, Dirk Rades, Andrew Wirth, Simon S. Lo, Brita L. Danielson, Laurie E. Gaspar, Paul W. Sperduto, Michael A. Vogelbaum, Jeffrey D. Radawski, Jian Z. Wang, Michael T. Gillin, Najeeb Mohideen, Carol A. Hahn, Eric L. Chang. (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline. Practical Radiation Oncology
CrossRef13
Maryam Rahman, J. Bridger Cox, Yueh-Yun Chi, Jamal H. Carter, William A. Friedman. (2012) Radiographic Response of Brain Metastasis after Linear Accelerator Radiosurgery. Stereotactic and Functional Neurosurgery 90:2, 69-78
CrossRef14
Rachel A. Freedman, Carey K. Anders. (2011) Treatment of Breast Cancer Brain Metastases. Current Breast Cancer Reports
CrossRef15
Elizabeth B. Claus. (2011) Neurosurgical management of metastases in the central nervous system. Nature Reviews Clinical Oncology
CrossRef16
Xiao-Bing Jiang, Qun-Ying Yang, Ke Sai, Xiang-Heng Zhang, Zhong-Ping Chen, Yong-Gao Mou. (2011) Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center. Tumor Biology 32:6, 1249-1256
CrossRef17
A. S. Jakola, S. Gulati, U. S. Nerland, O. Solheim. (2011) Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score. Journal of Neuro-Oncology 105:3, 573-581
CrossRef18
Grant K. Hunter, John H. Suh, Alwyn M. Reuther, Michael A. Vogelbaum, Gene H. Barnett, Lilyana Angelov, Robert J. Weil, Gennady Neyman, Samuel T. Chao. (2011) Treatment of Five or More Brain Metastases with Stereotactic Radiosurgery. International Journal of Radiation Oncology*Biology*Physics
CrossRef19
Eugene Koay, Erik P. Sulman. (2011) Management of Brain Metastasis: Past Lessons, Modern Management, and Future Considerations. Current Oncology Reports
CrossRef20
Kenji Hashimoto, Yoshitaka Narita, Yasuji Miyakita, Makoto Ohno, Minako Sumi, Hiroshi Mayahara, Takamasa Kayama, Soichiro Shibui. (2011) Comparison of Clinical Outcomes of Surgery Followed by Local Brain Radiotherapy and Surgery Followed by Whole Brain Radiotherapy in Patients With Single Brain Metastasis: Single-Center Retrospective Analysis. International Journal of Radiation Oncology*Biology*Physics 81:4, e475-e480
CrossRef21
Bethwel Raore, Matthew Schniederjan, Roshan Prabhu, Daniel J. Brat, Hui-Kuo Shu, Jeffrey J. Olson. (2011) Metastasis Infiltration: An Investigation of the Postoperative Brain–Tumor Interface. International Journal of Radiation Oncology*Biology*Physics 81:4, 1075-1080
CrossRef22
Henry S Park, Veronica L Chiang, Jonathan P Knisely, Ann C Raldow, James B Yu. (2011) Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update. Expert Review of Anticancer Therapy 11:11, 1731-1738
CrossRef23
Cyrus Chargari, Hind Riahi Idrissi, Jean-Yves Pierga, Marc A. Bollet, Véronique Diéras, François Campana, Paul Cottu, Alain Fourquet, Youlia M. Kirova. (2011) Preliminary Results of Whole Brain Radiotherapy With Concurrent Trastuzumab for Treatment of Brain Metastases in Breast Cancer Patients. International Journal of Radiation Oncology*Biology*Physics 81:3, 631-636
CrossRef24
Rodney E. Wegner, Adam C. Olson, Douglas Kondziolka, Ajay Niranjan, L. Dade Lundsford, John C. Flickinger. (2011) Stereotactic Radiosurgery for Patients With Brain Metastases From Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 81:3, e21-e27
CrossRef25
Ciprian Chira, Julian Jacob, Najib Derhem, Marc A. Bollet, François Campana, Virginie Marchand, Jean-Yves Pierga, Alain Fourquet, Youlia M. Kirova. (2011) Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapy. Journal of Neuro-Oncology 105:2, 401-408
CrossRef26
Timothy L. Siu, Rosalind L. Jeffree, John W. Fuller. (2011) Current strategies in the surgical management of cerebral metastases: an evidence-based review. Journal of Clinical Neuroscience 18:11, 1429-1434
CrossRef27
David Roberge, Ian Parney, Paul D. Brown. (2011) Radiosurgery to the Postoperative Surgical Cavity: Who Needs Evidence?. International Journal of Radiation Oncology*Biology*Physics
CrossRef28
Joshua Jones. (2011) Too Much, Too Little, or Just the Right Amount: Finding the Balance in Palliative Radiotherapy. Current Problems in Cancer 35:6, 325-336
CrossRef29
Melike Mut. (2011) Surgical treatment of brain metastasis: A review. Clinical Neurology and Neurosurgery
CrossRef30
Syed M. R. Kabir, Adrian T. H. Casey. 2011. Management of neurological complications in metastatic breast cancer. , 208-220.
CrossRef31
Anthony Chalmers, Richard Simcock. 2011. Palliative radiotherapy in the management of metastatic breast cancer. , 182-207.
CrossRef32
M. Buglione, L. Bandera, S. Grisanti, N. Pasinetti, P. Borghetti, F. Barbera, L. Triggiani, L. Costa, B. Shehi, B. Bonetti, S. Magrini. (2011) The impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients. La radiologia medica
CrossRef33
Lakshmi Nayak, Eudocia Quant Lee, Patrick Y. Wen. (2011) Epidemiology of Brain Metastases. Current Oncology Reports
CrossRef34
, Toshiaki Watanabe, Michio Itabashi, Yasuhiro Shimada, Shinji Tanaka, Yoshinori Ito, Yoichi Ajioka, Tetsuya Hamaguchi, Ichinosuke Hyodo, Masahiro Igarashi, Hideyuki Ishida, Megumi Ishiguro, Yukihide Kanemitsu, Norihiro Kokudo, Kei Muro, Atsushi Ochiai, Masahiko Oguchi, Yasuo Ohkura, Yutaka Saito, Yoshiharu Sakai, Hideki Ueno, Takayuki Yoshino, Takahiro Fujimori, Nobuo Koinuma, Takayuki Morita, Genichi Nishimura, Yuh Sakata, Keiichi Takahashi, Hiroya Takiuchi, Osamu Tsuruta, Toshiharu Yamaguchi, Masahiro Yoshida, Naohiko Yamaguchi, Kenjiro Kotake, Kenichi Sugihara. (2011) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. International Journal of Clinical Oncology
CrossRef35
Jung Ho Han, Dong Gyu Kim, Hyun-Tai Chung, Sun Ha Paek, Chul-Kee Park, Hee-Won Jung. (2011) Radiosurgery for Large Brain Metastases. International Journal of Radiation Oncology*Biology*Physics
CrossRef36
Yeon-Joo Kim, Kwan Ho Cho, Joo-Young Kim, Young Kyung Lim, Hye Sook Min, Sang Hyun Lee, Ho Jin Kim, Ho Shin Gwak, Heon Yoo, Seung Hoon Lee. (2011) Single-Dose Versus Fractionated Stereotactic Radiotherapy for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics 81:2, 483-489
CrossRef37
Hidefumi Aoyama. (2011) Radiation therapy for brain metastases in breast cancer patients. Breast Cancer 18:4, 244-251
CrossRef38
Maximilian I. Ruge, Philipp Kickingereder, Stefan Grau, Mauritius Hoevels, Harald Treuer, Volker Sturm. (2011) Stereotactic biopsy combined with stereotactic 125iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases. Journal of Neuro-Oncology 105:1, 109-118
CrossRef39
Kelly Jo Baldwin, Saša A. Živković, Frank S. Lieberman. (2011) Neurologic Emergencies in Patients Who Have Cancer: Diagnosis and Management. Neurologic Clinics
CrossRef40
Silvia Scoccianti, Umberto Ricardi. (2011) Treatment of brain metastases: Review of phase III randomized controlled trials. Radiotherapy and Oncology
CrossRef41
Paul Porensky, E Antonio Chiocca. (2011) Performing Quality Research in an Era of Reforms. Neurosurgery 69, 72-78
CrossRef42
S. G. Rogne, P. Rønning, E. Helseth, T. B. Johannesen, C. W. Langberg, K. Lote, D. Scheie, T. R. Meling. (2011) Craniotomy for brain metastases: a consecutive series of 316 patients. Acta Neurologica Scandinavicano-no
CrossRef43
P. Metellus. (2011) Les métastases cérébrales: actualités et innovations. Revue des Maladies Respiratoires Actualités 3:4, 410-414
CrossRef44
Xiang Zhang, Wei Zhang, Wei-Dong Cao, Gang Cheng, Bolin Liu, Jinxiang Cheng. (2011) A Review of Current Management of Brain Metastases. Annals of Surgical Oncology
CrossRef45
O. Bailon, A. Kallel, K. Chouahnia, S. Billot, D. Ferrari, A.-F. Carpentier. (2011) Les métastases cérébrales des cancers bronchiques non à petites cellules : vers une prise en charge homogène. Revue Neurologique 167:8-9, 579-591
CrossRef46
Vitaly Siomin, Jennifer L. Lin, Nicholas F. Marko, Gene H. Barnett, Steven A. Toms, Samuel T. Chao, Lilyana Angelov, Michael A. Vogelbaum, Kapila Navaratne, John H. Suh, Robert J. Weil. (2011) Stereotactic Radiosurgical Treatment of Brain Metastases to the Choroid Plexus. International Journal of Radiation Oncology*Biology*Physics 80:4, 1134-1142
CrossRef47
A. Niwińska, K. Pogoda, M. Murawska, P. Niwiński. (2011) Factors influencing survival in patients with breast cancer and single or solitary brain metastasis. European Journal of Surgical Oncology (EJSO) 37:7, 635-642
CrossRef48
Teresa Purzner, Jamie Purzner, Eric M Massicotte, Mark Bernstein. (2011) Outpatient Brain Tumor Surgery and Spinal Decompression: A Prospective Study of 1003 Patients. Neurosurgery 69:1, 119-127
CrossRef49
Stephen Rush, Robert E. Elliott, Amr Morsi, Nisha Mehta, Jeri Spriet, Ashwatha Narayana, Bernadine Donahue, Erik C. Parker, John G. Golfinos. (2011) Incidence, timing, and treatment of new brain metastases after Gamma Knife surgery for limited brain disease: the case for reducing the use of whole-brain radiation therapy. Journal of Neurosurgery 115:1, 37-48
CrossRef50
F. Heitz, J. Rochon, P. Harter, H.- J. Lueck, A. Fisseler-Eckhoff, J. Barinoff, A. Traut, F. Lorenz-Salehi, A. du Bois. (2011) Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival. Annals of Oncology 22:7, 1571-1581
CrossRef51
Julien Dinkel, Christian Thieke, Christian Plathow, Patrick Zamecnik, Hermann Prüm, Peter E. Huber, Hans-Ulrich Kauczor, Heinz-Peter Schlemmer, Christian M. Zechmann. (2011) Respiratory-Induced Prostate Motion. Strahlentherapie und Onkologie 187:7, 426-432
CrossRef52
I.A. Adamietz, S. Zeller. (2011) Strahlentherapie neuroendokriner Tumoren. Der Onkologe 17:7, 621-626
CrossRef53
Philipp Kiewe, Eckhard Thiel, Mark Reinwald, Agnieszka Korfel. (2011) Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors. Journal of Neuro-Oncology 103:3, 629-634
CrossRef54
Young Seok Park, Jong Hee Chang, Jin Woo Chang, Yong Gou Park. (2011) The efficacy of gamma knife radiosurgery for advanced gastric cancer with brain metastases. Journal of Neuro-Oncology 103:3, 513-521
CrossRef55
J. Walter, S. A. Kuhn, A. Waschke, R. Kalff, C. Ewald. (2011) Operative treatment of subcortical metastatic tumours in the central region. Journal of Neuro-Oncology 103:3, 567-573
CrossRef56
Jordi Remon, Pilar Lianes, Susana Martínez. (2011) Brain metastases from renal cell carcinoma. Should we change the current standard?. Cancer Treatment Reviews
CrossRef57
Giuseppe Roberto D’Agostino, Rosa Autorino, Angelo Pompucci, Maria Carmen Santis, Stefania Manfrida, Giuseppe Lella, Giovanna Mantini, Vincenzo Frascino, Silvia Chiesa, Alessio Albanese, Nicola Dinapoli, Luigi Azario, Alba Fiorentino, Vincenzo Valentini, Carmelo Anile, Mario Balducci. (2011) Whole-Brain Radiotherapy Combined with Surgery or Stereotactic Radiotherapy in Patients with Brain Oligometastases. Strahlentherapie und Onkologie
CrossRef58
Wook Ha Kim, Dong Gyu Kim, Jung Ho Han, Sun Ha Paek, Hyun-Tai Chung, Chul-Kee Park, Chae-Yong Kim, Yong Hwy Kim, Jin Wook Kim, Hee-Won Jung. (2011) Early Significant Tumor Volume Reduction After Radiosurgery in Brain Metastases from Renal Cell Carcinoma Results in Long-Term Survival. International Journal of Radiation Oncology*Biology*Physics
CrossRef59
Carsten Nieder, Oddvar Spanne, Minesh P. Mehta, Anca L. Grosu, Hans Geinitz. (2011) Presentation, patterns of care, and survival in patients with brain metastases. Cancer 117:11, 2505-2512
CrossRef60
Ameer L. Elaimy, Alexander R. Mackay, Wayne T. Lamoreaux, Robert K. Fairbanks, John J. Demakas, Barton S. Cooke, Christopher M. Lee. (2011) Clinical Outcomes of Stereotactic Radiosurgery in the Treatment of Patients with Metastatic Brain Tumors. World Neurosurgery 75:5-6, 673-683
CrossRef61
Joseph C.T. Chen. (2011) Radiosurgery for Melanoma Metastases to Brain. World Neurosurgery 75:5-6, 598-599
CrossRef62
Susan C. Pannullo, Justin F. Fraser, Jennifer Moliterno, William Cobb, Philip E. Stieg. (2011) Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease. Journal of Neuro-Oncology 103:1, 1-17
CrossRef63
Andrés Server, Tone E. Døli Orheim, Bjørn A. Graff, Roger Josefsen, Theresa Kumar, Per H. Nakstad. (2011) Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology 53:5, 319-330
CrossRef64
April F. Eichler, Euiheon Chung, David P. Kodack, Jay S. Loeffler, Dai Fukumura, Rakesh K. Jain. (2011) The biology of brain metastases—translation to new therapies. Nature Reviews Clinical Oncology
CrossRef65
L.-O. Mügge, A. Schüler, A. Hochhaus. (2011) Therapie von Hirnmetastasen und Meningeosis neoplastica. Der Onkologe 17:4, 292-307
CrossRef66
Lincy S Lal, Luisa Franzini, Janki Panchal, Eric Chang, Christina A Meyers, J Michael Swint. (2011) Economic impact of stereotactic radiosurgery for malignant intracranial brain tumors. Expert Review of Pharmacoeconomics & Outcomes Research 11:2, 195-204
CrossRef67
Ryuya Yamanaka, Hatsuyo Koga, Yousuke Yamamoto, Shinichi Yamada, Tomomi Sano, Tetsushi Fukushige. (2011) Characteristics of patients with brain metastases from lung cancer in a palliative care center. Supportive Care in Cancer 19:4, 467-473
CrossRef68
2011. Neoplasms. , 118-204.
CrossRef69
Mu-min Shao, Jun Liu, Joaquim S. Vong, Yun Niu, Barbara Germin, Ping Tang, Anthony W.H. Chan, Philip C.W. Lui, Bonita K.B. Law, Puay-Hoon Tan, Gary M. Tse. (2011) A subset of breast cancer predisposes to brain metastasis. Medical Molecular Morphology 44:1, 15-20
CrossRef70
Daniel Roos. (2011) What is the randomised evidence for surgery and stereotactic radiosurgery for patients with solitary (or few) brain metastases?. International Journal of Evidence-Based Healthcare 9:1, 61-66
CrossRef71
Daniel S. Higginson, David E. Morris, Ellen L. Jones, Daniel Clarke-Pearson, Mahesh A. Varia. (2011) Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology. Gynecologic Oncology 120:3, 404-412
CrossRef72
Kevin S Cahill, John H Chi, Art L Day, Elizabeth B Claus. (2011) Trends in Survival After Surgery for Breast Cancer Metastatic to the Brain and Spinal Column in Medicare Patients: A Population-Based Analysis. Neurosurgery 68:3, 705-713
CrossRef73
N. Mollberg, M. Surati, C. Demchuk, R. Fathi, A. K. Salama, A. N. Husain, T. Hensing, R. Salgia. (2011) Mind-mapping for lung cancer: Towards a personalized therapeutics approach. Advances in Therapy 28:3, 173-194
CrossRef74
Rachel Grossman, Debraj Mukherjee, David C. Chang, Michael Purtell, Michael Lim, Henry Brem, Alfredo Quiñones-Hinojosa. (2011) Predictors of Inpatient Death and Complications among Postoperative Elderly Patients with Metastatic Brain Tumors. Annals of Surgical Oncology 18:2, 521-528
CrossRef75
Maximilian I Ruge, Bogdana Suchorska, Mohammad Maarouf, Matthias Runge, Harald Treuer, Jurgen J Voges, Volker Sturm. (2011) Stereotactic 125Iodine Brachytherapy for the Treatment of Singular Brain Metastases. Closing a Gap?. Neurosurgery1
CrossRef76
Joline S.W. Lind, Frank J. Lagerwaard, Egbert F. Smit, Pieter E. Postmus, Ben J. Slotman, Suresh Senan. (2011) Time for reappraisal of extracranial treatment options?. Cancer 117:3, 597-605
CrossRef77
Lincy S. Lal, Stacey DaCosta Byfield, Eric L. Chang, Luisa Franzini, Lesley-Ann Miller, Rebecca Arbuckle, Liezl Reasonda, Chun Feng, Andrea Adamus, John Michael Swint. (2011) Cost-effectiveness Analysis of a Randomized Study Comparing Radiosurgery With Radiosurgery and Whole Brain Radiation Therapy in Patients With 1 to 3 Brain Metastases. American Journal of Clinical Oncology1
CrossRef78
Peter S. Craighead, Alexander Chan. (2011) Defining treatment for brain metastases patients: nihilism versus optimism. Supportive Care in Cancer
CrossRef79
Gang Chen, Zhou Wang, Xiang-yan Liu, Fan-ying Liu. (2011) High-Level CXCR4 Expression Correlates with Brain-Specific Metastasis of Non-Small Cell Lung Cancer. World Journal of Surgery 35:1, 56-61
CrossRef80
Maximilian I. Ruge, Martin Kocher, Mohammad Maarouf, Christina Hamisch, Harald Treuer, Jürgen Voges, Volker Sturm. (2011) Comparison of Stereotactic Brachytherapy (125Iodine Seeds) with Stereotactic Radiosurgery (LINAC) for the Treatment of Singular Cerebral Metastases. Strahlentherapie und Onkologie 187:1, 7-14
CrossRef81
Heon Yoo, Eugene Jung, Ho Shin Gwak, Sang Hoon Shin, Seung Hoon Lee. (2011) Surgical Outcomes of Hemorrhagic Metastatic Brain Tumors. Cancer Research and Treatment 43:2, 102
CrossRef82
Joseph K. Salama, Michael D. Hasselle, Steven J. Chmura, Renuka Malik, Neil Mehta, Kamil M. Yenice, Victoria M. Villaflor, Walter M. Stadler, Philip C. Hoffman, Ezra E. W. Cohen, Philip P. Connell, Daniel J. Haraf, Everett E. Vokes, Samuel Hellman, Ralph R. Weichselbaum. (2011) Stereotactic body radiotherapy for multisite extracranial oligometastases. Cancern/a-n/a
CrossRef83
Zhiyuan Xu, Nicholas F. Marko, Lilyana Angelov, Gene H. Barnett, Samuel T. Chao, Michael A. Vogelbaum, John H. Suh, Robert J. Weil. (2011) Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer. Cancern/a-n/a
CrossRef84
Ameer L Elaimy, Alexander R Mackay, Wayne T Lamoreaux, Robert K Fairbanks, John J Demakas, Barton S Cooke, Benjamin J Peressini, John T Holbrook, Christopher M Lee. (2011) Multimodality treatment of brain metastases: an institutional survival analysis of 275 patients. World Journal of Surgical Oncology 9:1, 69
CrossRef85
Damien C Weber, Francesca Caparrotti, Mohamed Laouiti, Karim Malek. (2011) Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life. Radiation Oncology 6:1, 79
CrossRef86
Jean-Claude M. Rwigema, Rodney E. Wegner, Arlan H. Mintz, Anthony J. Paravati, Steven A. Burton, Cihat Ozhasoglu, Dwight E. Heron. (2011) Stereotactic Radiosurgery to the Resection Cavity of Brain Metastases: A Retrospective Analysis and Literature Review. Stereotactic and Functional Neurosurgery 89:6, 329-337
CrossRef87
Oscar Arrieta, Cynthia Villarreal-Garza, Jesus Zamora, Monika Blake-Cerda, Maria D de la Mata, Diego G Zavala, Sae Muniz-Hernandez, Jaime de la Garza. (2011) Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation.. Radiation Oncology 6:1, 166
CrossRef88
Robert B. Den, David W. Andrews. (2011) Radiotherapy for Brain Metastases. Neurosurgery Clinics of North America 22:1, 37-44
CrossRef89
Mariana E. Witgert, Christina A. Meyers. (2011) Neurocognitive and Quality of Life Measures in Patients with Metastatic Brain Disease. Neurosurgery Clinics of North America 22:1, 79-85
CrossRef90
Muhammad M. Abd-El-Barr, Maryam Rahman, Ganesh Rao. (2011) Investigational Therapies for Brain Metastases. Neurosurgery Clinics of North America 22:1, 87-96
CrossRef91
Christopher P. Kellner, Anthony L. D’Ambrosio. (2011) Surgical Management of Brain Metastases. Neurosurgery Clinics of North America 22:1, 53-59
CrossRef92
Paul J. Kelly, Yijie Brittany Lin, Alvin Y. Yu, Brian M. Alexander, Fred Hacker, Karen J. Marcus, Stephanie E. Weiss. (2010) Stereotactic Irradiation of the Postoperative Resection Cavity for Brain Metastasis: A Frameless Linear Accelerator-Based Case Series and Review of the Technique. International Journal of Radiation OncologyBiologyPhysics
CrossRef93
Vinai Gondi, Minesh P Mehta. (2010) Novel insights into the management of brain metastases. Current Opinion in Neurology 23:6, 556-562
CrossRef94
Cyrus Chargari, François Campana, Jean-Yves Pierga, Lionel Védrine, Damien Ricard, Sylvestre Le Moulec, Alain Fourquet, Youlia M. Kirova. (2010) Whole-brain radiation therapy in breast cancer patients with brain metastases. Nature Reviews Clinical Oncology 7:11, 632-640
CrossRef95
Munzir Al-Zabin, Winfried O. Ullrich, Alexander Brawanski, Martin A. Proescholdt. (2010) Recurrent brain metastases from lung cancer: the impact of reoperation. Acta Neurochirurgica 152:11, 1887-1892
CrossRef96
Paul A. Saconn, Edward G. Shaw, Michael D. Chan, Sarah E. Squire, Annette J. Johnson, Kevin P. McMullen, Stephen B. Tatter, Thomas L. Ellis, James Lovato, J. Daniel Bourland, Kenneth E. Ekstrand, Allan F. DeGuzman, Michael T. Munley. (2010) Use of 3.0-T MRI for Stereotactic Radiosurgery Planning for Treatment of Brain Metastases: A Single-Institution Retrospective Review. International Journal of Radiation Oncology*Biology*Physics 78:4, 1142-1146
CrossRef97
Yvonne Kienast, Frank Winkler. (2010) Therapy and prophylaxis of brain metastases. Expert Review of Anticancer Therapy 10:11, 1763-1777
CrossRef98
Daniel E. Roos, Brian P Brophy, James Taylor. (2010) Lessons from a 17-Year Radiosurgery Experience at the Royal Adelaide Hospital. International Journal of Radiation OncologyBiologyPhysics
CrossRef99
R. Soffietti, P. Cornu, J. Y. Delattre, R. Grant, F. Graus, W. Grisold, J. Heimans, J. Hildebrand, P. Hoskin, M. Kalljo, P. Krauseneck, C. Marosi, T. Siegal, C. Vecht. 2010. Brain Metastases. , 437-445.
CrossRef100
Doo-Sik Kong, Jung-Il Lee, Yong-Seok Im, Do-Hyun Nam, Kwan Park, Jong-Hyun Kim. (2010) Differential Impact of Whole-Brain Radiotherapy Added to Radiosurgery for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics 78:2, 385-389
CrossRef101
Dirk Rades, Christine Heisterkamp, Steven E. Schild. (2010) Do Patients Receiving Whole-Brain Radiotherapy for Brain Metastases From Renal Cell Carcinoma Benefit From Escalation of the Radiation Dose?. International Journal of Radiation Oncology*Biology*Physics 78:2, 398-403
CrossRef102
Simon S. Lo, James W. Clarke, John C. Grecula, John M. McGregor, Nina A. Mayr, Robert Cavaliere, Kari L. Kendra, Nilendu Gupta, Jian Z. Wang, Atom Sarkar, Thomas E. Olencki. (2010) Stereotactic radiosurgery alone for patients with 1–4 radioresistant brain metastases. Medical Oncology
CrossRef103
J.R. Marsden, J.A. Newton-Bishop, L. Burrows, M. Cook, P.G. Corrie, N.H. Cox, M.E. Gore, P. Lorigan, R. MacKie, P. Nathan, H. Peach, B. Powell, C. Walker. (2010) Revised UK guidelines for the management of cutaneous melanoma 2010. Journal of Plastic, Reconstructive & Aesthetic Surgery 63:9, 1401-1419
CrossRef104
Stephen Lutz, Timothy Korytko, Janet Nguyen, Luluel Khan, Edward Chow, Benjamin Corn. (2010) Palliative Radiotherapy. The Cancer Journal 16:5, 473-482
CrossRef105
Hemant Sarin. (2010) Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors. Therapeutic Delivery 1:2, 289-305
CrossRef106
Christopher S. Platta, Deepak Khuntia, Minesh P. Mehta, John H. Suh. (2010) Current Treatment Strategies for Brain Metastasis and Complications From Therapeutic Techniques. American Journal of Clinical Oncology 33:4, 398-407
CrossRef107
Akash J. Patel, Dima Suki, Mustafa Aziz Hatiboglu, Hiba Abouassi, Weiming Shi, David M. Wildrick, Frederick F. Lang, Raymond Sawaya. (2010) Factors influencing the risk of local recurrence after resection of a single brain metastasis. Journal of Neurosurgery 113:2, 181-189
CrossRef108
Gianluca Tomasello, Philippe L. Bedard, Evandro de Azambuja, Dominique Lossignol, Daniel Devriendt, Martine J. Piccart-Gebhart. (2010) Brain metastases in HER2-positive breast cancer: The evolving role of lapatinib. Critical Reviews in Oncology/Hematology 75:2, 110-121
CrossRef109
P.H. Graham, J. Bucci, L. Browne. (2010) Randomized Comparison of Whole Brain Radiotherapy, 20 Gy in Four Daily Fractions Versus 40 Gy in 20 Twice-Daily Fractions, for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics 77:3, 648-654
CrossRef110
Paul W. Sperduto, Samuel T. Chao, Penny K. Sneed, Xianghua Luo, John Suh, David Roberge, Amit Bhatt, Ashley W. Jensen, Paul D. Brown, Helen Shih, John Kirkpatrick, Amanda Schwer, Laurie E. Gaspar, John B. Fiveash, Veronica Chiang, Jonathan Knisely, Christina Maria Sperduto, Minesh Mehta. (2010) Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients. International Journal of Radiation Oncology*Biology*Physics 77:3, 655-661
CrossRef111
Wael Hassaneen, Dima Suki, Abhijit L. Salaskar, David M. Wildrick, Frederick F. Lang, Gregory N. Fuller, Raymond Sawaya. (2010) Surgical management of lateral-ventricle metastases: report of 29 cases in a single-institution experience. Journal of Neurosurgery 112:5, 1046-1055
CrossRef112
John H. Suh, Gregory M.M. Videtic, Amr M. Aref, Isabelle Germano, Brian J. Goldsmith, Joseph P. Imperato, Karen J. Marcus, Michael W. McDermott, Mark W. McDonald, Roy A. Patchell, H. Ian Robins, C. Leland Rogers, Aaron H. Wolfson, Franz J. Wippold, Laurie E. Gaspar. (2010) ACR Appropriateness Criteria®: Single Brain Metastasis. Current Problems in Cancer 34:3, 162-174
CrossRef113
Marc C Chamberlain. (2010) Brain metastases: a medical neuro-oncology perspective. Expert Review of Neurotherapeutics 10:4, 563-573
CrossRef114
Nicholas F. Marko, Robert J. Weil. (2010) Radiotherapy: Neurocognitive considerations in the treatment of brain metastases. Nature Reviews Clinical Oncology 7:4, 185-186
CrossRef115
Jung Ho Han, Dong Gyu Kim, Hyun-Tai Chung, Chae-Yong Kim, Chul-Kee Park, Young Seob Chung, Sun Ha Paek, Moon-Won Yoo, Baek-Hui Kim, Hee-Won Jung. (2010) Radiosurgery for brain metastasis from advanced gastric cancer. Acta Neurochirurgica 152:4, 605-610
CrossRef116
Alexander Muacevic, Markus Kufeld, Berndt Wowra, Friedrich-Wilhelm Kreth, Jörg-Christian Tonn. (2010) Feasibility, safety, and outcome of frameless image-guided robotic radiosurgery for brain metastases. Journal of Neuro-Oncology 97:2, 267-274
CrossRef117
Tina Wang, Rebecca A. Nelson, Alicia Bogardus, Frederic W. Grannis. (2010) Five-year lung cancer survival. Cancer 116:6, 1518-1525
CrossRef118
Serena Ricciardi, Filippo de Marinis. (2010) Multimodality management of non-small cell lung cancer patients with brain metastases. Current Opinion in Oncology 22:2, 86-93
CrossRef119
James W. Clarke, Steven Register, John M. McGregor, John C. Grecula, Nina A. Mayr, Jian Z. Wang, Kaile Li, Nilendu Gupta, Kari L. Kendra, Thomas E. Olencki, Robert Cavaliere, Atom Sarkar, Simon S. Lo. (2010) Stereotactic Radiosurgery With or Without Whole Brain Radiotherapy for Patients With a Single Radioresistant Brain Metastasis. American Journal of Clinical Oncology 33:1, 70-74
CrossRef120
Mario Teo, Sam Eljamel. (2010) Endoscopic resection. Journal of Neurosurgery 112:2, 473-474
CrossRef121
D. Bottke, T. Wiegel. (2010) Palliative strahlentherapeutische Konzepte bei Patienten mit Nierenzellkarzinom. Der Onkologe 16:2, 168-174
CrossRef122
P Sundaresan, R Yeghiaian-Alvandi, V Gebski. (2010) Prognostic index to identify patients who may not benefit from whole brain radiotherapy for multiple brain metastases from lung cancer. Journal of Medical Imaging and Radiation Oncology 54:1, 69-75
CrossRef123
, Paula Manchon, Josep M. Borràs, Tàrsila Ferro, Josep Alfons Espinàs. (2010) Breast cancer OncoGuia. Clinical and Translational Oncology 12:2, 113-137
CrossRef124
Steven N. Kalkanis, Douglas Kondziolka, Laurie E. Gaspar, Stuart H. Burri, Anthony L. Asher, Charles S. Cobbs, Mario Ammirati, Paula D. Robinson, David W. Andrews, Jay S. Loeffler, Michael McDermott, Minesh P. Mehta, Tom Mikkelsen, Jeffrey J. Olson, Nina A. Paleologos, Roy A. Patchell, Timothy C. Ryken, Mark E. Linskey. (2010) The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology 96:1, 33-43
CrossRef125
Takeshi Okuda, Kazuo Kataoka, Tomonari Yabuuchi, Haruki Yugami, Amami Kato. (2010) Fluorescence-guided surgery of metastatic brain tumors using fluorescein sodium. Journal of Clinical Neuroscience 17:1, 118-121
CrossRef126
Stanley H. Benedict, Kamil M. Yenice, David Followill, James M. Galvin, William Hinson, Brian Kavanagh, Paul Keall, Michael Lovelock, Sanford Meeks, Lech Papiez, Thomas Purdie, Ramaswamy Sadagopan, Michael C. Schell, Bill Salter, David J. Schlesinger, Almon S. Shiu, Timothy Solberg, Danny Y. Song, Volker Stieber, Robert Timmerman, Wolfgang A. Tomé, Dirk Verellen, Lu Wang, Fang-Fang Yin. (2010) Stereotactic body radiation therapy: The report of AAPM Task Group 101. Medical Physics 37:8, 4078
CrossRef127
Martin J. Edelman, Chandra P. Belani, Mark A. Socinski, Rafat H. Ansari, Coleman K. Obasaju, Ruqin Chen, Matthew J. Monberg, Joseph Treat. (2010) Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology 5:1, 110-116
CrossRef128
Robert D. Ambrosini, Peng Wang, Walter G. O'Dell. (2010) Computer-aided detection of metastatic brain tumors using automated three-dimensional template matching. Journal of Magnetic Resonance Imaging 31:1, 85-93
CrossRef129
Jacob Staley, Patrick Grogan, Abbas K. Samadi, Huizhong Cui, Mark S. Cohen, Xinmai Yang. (2010) Growth of melanoma brain tumors monitored by photoacoustic microscopy. Journal of Biomedical Optics 15:4, 040510
CrossRef130
Laurie E. Gaspar, Minesh P. Mehta, Roy A. Patchell, Stuart H. Burri, Paula D. Robinson, Rachel E. Morris, Mario Ammirati, David W. Andrews, Anthony L. Asher, Charles S. Cobbs, Douglas Kondziolka, Mark E. Linskey, Jay S. Loeffler, Michael McDermott, Tom Mikkelsen, Jeffrey J. Olson, Nina A. Paleologos, Timothy C. Ryken, Steven N. Kalkanis. (2010) The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology 96:1, 17-32
CrossRef131
Mark E. Linskey, David W. Andrews, Anthony L. Asher, Stuart H. Burri, Douglas Kondziolka, Paula D. Robinson, Mario Ammirati, Charles S. Cobbs, Laurie E. Gaspar, Jay S. Loeffler, Michael McDermott, Minesh P. Mehta, Tom Mikkelsen, Jeffrey J. Olson, Nina A. Paleologos, Roy A. Patchell, Timothy C. Ryken, Steven N. Kalkanis. (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology 96:1, 45-68
CrossRef132
A. Gabriella Wernicke, David L. Sherr, Theodore H. Schwartz, Susan C. Pannullo, Philip E. Stieg, John A. Boockvar, Jennifer A. Moliterno, Jana Ivanidze, Samuel Trichter, Albert M. Sabbas, Bhupesh Parashar, Dattatreyudu Nori. (2010) The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: Outcomes and toxicities of a prospective study. Brachytherapy 9:1, 91-99
CrossRef133
Sajeve S. Thomas, Erin M. Dunbar. (2010) Modern Multidisciplinary Management of Brain Metastases. Current Oncology Reports 12:1, 34-40
CrossRef134
Kyoichi Kaira, Toshiaki Takahashi, Haruyasu Murakami, Asuka Tsuya, Yukiko Nakamura, Tateaki Naito, Masahiro Endo, Nobuyuki Yamamoto. (2010) Long-term survivors of more than 5 years in advanced non-small cell lung cancer. Lung Cancer 67:1, 120-123
CrossRef135
David J. Stewart. 2010. Clinical Management of Lung Cancer. , 437-445.
CrossRef136
Christian Senft, Christian T. Ulrich, Volker Seifert, Thomas Gasser. (2010) Intraoperative magnetic resonance imaging in the surgical treatment of cerebral metastases. Journal of Surgical Oncologyn/a-n/a
CrossRef137
C. Hallermann, J. Atzpodien, M. Klein, A. Krause-Bergmann, G. Brodner, G. Strittmatter, G. Brunner, H.-J. Schulze. (2009) Malignes Melanom. best practice onkologie 4:6, 4-22
CrossRef138
Brian J. Karlovits, Matthew R. Quigley, Stephen M. Karlovits, Lindsay Miller, Mark Johnson, Olivier Gayou, Russell Fuhrer. (2009) Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurgical FOCUS 27:6, E7
CrossRef139
Christopher J. Carrubba, Todd W. Vitaz. (2009) Factors affecting the outcome after treatment for metastatic melanoma to the brain. Surgical Neurology 72:6, 707-711
CrossRef140
Takeshi Okuda, Yoshifumi Teramoto, Haruki Yugami, Kazuo Kataoka, Amami Kato. (2009) Surgical technique for a cystic-type metastatic brain tumor: transformation to a solid-type tumor using hydrofiber dressing. Surgical Neurology 72:6, 703-706
CrossRef141
Florian Heitz, Philipp Harter, Hans-Joachim Lueck, Annette Fissler-Eckhoff, Fatemeh Lorenz-Salehi, Stefanie Scheil-Bertram, Alexander Traut, Andreas du Bois. (2009) Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases. European Journal of Cancer 45:16, 2792-2798
CrossRef142
Carsten Nieder, Roy M. Bremnes, Nicolaus H. Andratschke. (2009) Prognostic Scores in Patients with Brain Metastases from Non-small Cell Lung Cancer. Journal of Thoracic Oncology 4:11, 1337-1341
CrossRef143
(2009) Cancer du sein métastatique. Oncologie 11:11, 552-588
CrossRef144
Jonathan PS Knisely. (2009) Focused attention on brain metastases. The Lancet Oncology 10:11, 1024
CrossRef145
S. G. Rogne, A. Konglund, T. R. Meling, D. Scheie, T. B. Johannesen, P. Rønning, E. Helseth. (2009) Intracranial tumor surgery in patients >70 years of age: is clinical practice worthwhile or futile?. Acta Neurologica Scandinavica 120:5, 288-294
CrossRef146
Eric L Chang, Jeffrey S Wefel, Kenneth R Hess, Pamela K Allen, Frederick F Lang, David G Kornguth, Rebecca B Arbuckle, J Michael Swint, Almon S Shiu, Moshe H Maor, Christina A Meyers. (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. The Lancet Oncology 10:11, 1037-1044
CrossRef147
David Roberge, Kevin Petrecca, Munir El Refae, Luis Souhami. (2009) Whole-brain radiotherapy and tumor bed radiosurgery following resection of solitary brain metastases. Journal of Neuro-Oncology 95:1, 95-99
CrossRef148
Hideyuki Kano, Douglas Kondziolka, Oscar Zorro, Javier Lobato-Polo, John C. Flickinger, L. Dade Lunsford. (2009) The results of resection after stereotactic radiosurgery for brain metastases. Journal of Neurosurgery 111:4, 825-831
CrossRef149
Daniel Pop, Ahmad S. Nadeemy, Nicolas Venissac, Patrice Guiraudet, Josiane Otto, Michel Poudenx, Jérôme Mouroux. (2009) Skeletal Muscle Metastasis from Non-small Cell Lung Cancer. Journal of Thoracic Oncology 4:10, 1236-1241
CrossRef150
Jay Jagannathan, Chun-Po Yen, Dibyendu Kumar Ray, David Schlesinger, Rod J. Oskouian, Nader Pouratian, Mark E. Shaffrey, James Larner, Jason P. Sheehan. (2009) Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases. Journal of Neurosurgery 111:3, 431-438
CrossRef151
Arnaldo Neves Da Silva, Kazuki Nagayama, David J. Schlesinger, Jason P. Sheehan. (2009) Gamma Knife surgery for brain metastases from gastrointestinal cancer. Journal of Neurosurgery 111:3, 423-430
CrossRef152
F. Aziz, S. Telara, H. Moseley, C. Goodman, P. Manthri, M. Sam Eljamel. (2009) Photodynamic therapy adjuvant to surgery in metastatic carcinoma in brain. Photodiagnosis and Photodynamic Therapy 6:3-4, 227-230
CrossRef153
Christoffer Gebhardt, Helmut Näher. (2009) Standards und Trends bei der Behandlung des malignen Melanoms. Onkopipeline 2:3, 101-113
CrossRef154
Peter Lindvall, Per Bergström, Per-Olov Löfroth, A. Tommy Bergenheim. (2009) A comparison between surgical resection in combination with WBRT or hypofractionated stereotactic irradiation in the treatment of solitary brain metastases. Acta Neurochirurgica 151:9, 1053-1059
CrossRef155
Brian J. Williams, Dima Suki, Benjamin D. Fox, Christopher E. Pelloski, Marcos V. C. Maldaun, Raymond E. Sawaya, Frederick F. Lang, Ganesh Rao. (2009) Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. Journal of Neurosurgery 111:3, 439-448
CrossRef156
Soichiro Shibui. (2009) Treatment of metastatic brain tumors. International Journal of Clinical Oncology 14:4, 273-274
CrossRef157
Toru Serizawa. (2009) Radiosurgery for metastatic brain tumors. International Journal of Clinical Oncology 14:4, 289-298
CrossRef158
A. Testori, P. Rutkowski, J. Marsden, L. Bastholt, V. Chiarion-Sileni, A. Hauschild, A. M. M. Eggermont. (2009) Surgery and radiotherapy in the treatment of cutaneous melanoma. Annals of Oncology 20:Supplement 6, vi22-vi29
CrossRef159
Alberto Franzin, Silvia Snider, Piero Picozzi, Angelo Bolognesi, Carlo Serra, Alberto Vimercati, Olga Passarin, Pietro Mortini. (2009) Evaluation of Different Score Index for Predicting Prognosis in Gamma Knife Radiosurgical Treatment for Brain Metastasis. International Journal of Radiation Oncology*Biology*Physics 74:3, 707-713
CrossRef160
J. M. Bravo Marques. (2009) Treatment of brain metastases in patients with HER2+ breast cancer. Advances in Therapy 26:S1, 18-26
CrossRef161
Elena S. Ratner, Eugene Toy, David M. O'Malley, Jessica McAlpine, Thomas J. Rutherford, Masoud Azodi, Susan A. Higgins, Peter E. Schwartz. (2009) Brain Metastases in Epithelial Ovarian and Primary Peritoneal Carcinoma. International Journal of Gynecological Cancer 19:5, 856-859
CrossRef162
Laura A. Vallow. (2009) Surgery: Stereotactic radiosurgery alone to treat brain metastases. Nature Reviews Clinical Oncology 6:7, 377-378
CrossRef163
Tulika Ranjan, Lauren E. Abrey. (2009) Current management of metastatic brain disease. Neurotherapeutics 6:3, 598-603
CrossRef164
Friso W. A. Hoefnagels, Frank J. Lagerwaard, Esther Sanchez, Cornelis J. A. Haasbeek, Dirk L. Knol, Ben J. Slotman, W. Peter Vandertop. (2009) Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. Journal of Neurology 256:6, 878-887
CrossRef165
Se-Hyuk Kim, Robert J Weil. (2009) Treatment options for elderly patients with brain metastasis from systemic cancer. Aging Health 5:3, 323-331
CrossRef166
Arturo Navarro-Martín, Ann Maitz, Michelle Manders, Emily Ducharme, Peter Chen, Inga Grills. (2009) Gamma Knife radiosurgery as a primary treatment option for solitary brain metastases from ovarian carcinoma. Clinical and Translational Oncology 11:5, 326-328
CrossRef167
Michael A. Vogelbaum, Anthony L. Asher, Douglas Kondziolka, Nicholas M. Boulis, Nathan R. Selden, Brian L. Hoh, Fred G. Barker. (2009) Modern treatment of cerebral metastases: Integrated Medical LearningSM at CNS 2007. Journal of Neuro-Oncology 93:1, 89-105
CrossRef168
Brian E Lally, James J Urbanic, A William Blackstock. (2009) Could it be that less is more?. The Lancet Oncology 10:5, 435-437
CrossRef169
John H. Suh, Samuel T. Chao, Michael A. Vogelbaum. (2009) Management of brain metastases. Current Neurology and Neuroscience Reports 9:3, 223-230
CrossRef170
Steven E Schild. (2009) Role of radiation therapy in the treatment of melanoma. Expert Review of Anticancer Therapy 9:5, 583-586
CrossRef171
Falk Müller-Riemenschneider, Angelina Bockelbrink, Iris Ernst, Christoph Schwarzbach, Christoph Vauth, J.-Matthias Graf von der Schulenburg, Stefan N. Willich. (2009) Stereotactic radiosurgery for the treatment of brain metastases. Radiotherapy and Oncology 91:1, 67-74
CrossRef172
Hui Li, Sheng-cai Hou, Bin Hu, Tong Li, Yang Wang, Jin-bai Miao, Bin You, Yi-li Fu. (2009) Surgery versus stereotactic radiosurgery for single synchronous brain metastasis from non-small cell lung cancer. Chinese Journal of Cancer Research 21:1, 56-60
CrossRef173
Jung Han Kim, Hyeong Su Kim, Jung Hye Kwon, Sarah Park, Ho Young Kim, Joo Young Jung, Hyo Jung Kim, Hun Ho Song, Gyeong-Won Lee, Soon Il Lee, Soo Jung Gong, Jung-Ae Lee, Kyoung Ju Kim, Dae Young Zang. (2009) Systemic chemotherapy after cranial irradiation in patients with brain metastases from non-small cell lung cancer: A retrospective study. Lung Cancer 63:3, 405-409
CrossRef174
Thomas Sweets, R. Bruce Bracken, Eric J. Geisler, Ronald Warnick. (2009) Intracranial Treatment for Solitary Prostatic Adenocarcinoma Brain Metastasis is Curative. Urology 73:3, 681.e7-681.e9
CrossRef175
Ly Do, Richard Pezner, Eric Radany, An Liu, Cecil Staud, Benham Badie. (2009) Resection Followed by Stereotactic Radiosurgery to Resection Cavity for Intracranial Metastases. International Journal of Radiation Oncology*Biology*Physics 73:2, 486-491
CrossRef176
T Neuhaus, Y Ko, R P Muller, G G Grabenbauer, J P Hedde, H Schueller, M Kocher, S Stier, R Fietkau. (2009) A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer. British Journal of Cancer 100:2, 291-297
CrossRef177
Won Hyoung Park, In Seok Jang, Chang Jin Kim, Do Hoon Kwon. (2009) Gamma Knife Radiosurgery after Stereotactic Aspiration for Large Cystic Brain Metastases. Journal of Korean Neurosurgical Society 46:4, 360
CrossRef178
Anthony H. Sin, Raul J. Cardenas, Prasad Vannemreddy, Anil Nanda. (2009) Gamma Knife® Stereotactic Radiosurgery for Intracranial Metastases from Conventionally Radioresistant Primary Cancers: Outcome Analysis of Survival and Control of Brain Disease. Southern Medical Journal 102:1, 42-44
CrossRef179
Cheoljin Kim, Miyoung Baek, Sungkwang Park, Kijung Ahn, Heunglae Cho. (2009) Comparison of Stereotactic Radiosurgery and Whole Brain Radiotherapy in Patients with Four or More Brain Metastases. The Journal of the Korean Society for Therapeutic Radiology and Oncology 27:3, 163
CrossRef180
Young Zoon Kim, Kyu Hong Kim, Joon Soo Kim, Yeong Jin Song, Ki Uk Kim, Hyung Dong Kim. (2009) Clinical Analysis of Patients who Survived for Less than 3 Months After Brain Metastatectomy. Journal of Korean Medical Science 24:4, 641
CrossRef181
Hae-Won Gu, Moon-Jun Sohn, Dong-Joon Lee, Hye Ran Lee, Chae-Heuck Lee, C. Jin Whang. (2009) Clinical Analysis of Novalis Stereotactic Radiosurgery for Brain Metastases. Journal of Korean Neurosurgical Society 46:3, 245
CrossRef182
Amin B. Kassam, Johnathan A. Engh, Arlan H. Mintz, Daniel M. Prevedello. (2009) Completely endoscopic resection of intraparenchymal brain tumors. Journal of Neurosurgery 110:1, 116-123
CrossRef183
Hee Keun Gwak, Woo Chul Kim, Hun Jung Kim, Jung Hoon Park, Chang Hoon Song. (2009) Survival Analysis of Patients with Brain Metastsis by Weighting According to the Primary Tumor Oncotype. The Journal of the Korean Society for Therapeutic Radiology and Oncology 27:3, 140
CrossRef184
Virginia Wolstenholme, Maria Hawkins, Sue Ashley, Diana Tait, Gillian Ross. (2008) HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients. The Breast 17:6, 661-665
CrossRef185
K. Matsumoto, M. Ando, C. Yamauchi, C. Egawa, Y. Hamamoto, M. Kataoka, T. Shuto, K. Karasawa, M. Kurosumi, N. Kan, M. Mitsumori. (2008) Questionnaire Survey of Treatment Choice for Breast Cancer Patients with Brain Metastasis in Japan: Results of a Nationwide Survey by the Task Force of the Japanese Breast Cancer Society. Japanese Journal of Clinical Oncology 39:1, 22-26
CrossRef186
Steve R. Martinez, Shawn E. Young. (2008) A rational surgical approach to the treatment of distant melanoma metastases. Cancer Treatment Reviews 34:7, 614-620
CrossRef187
Im Il Na, Tae Hyun Lee, Du Hwan Choe, Gi Jeong Cheon, Cheol Hyeon Kim, Jae Soo Koh, HeeJong Baek, Baek-Yeol Ryoo, Sung Hyun Yang, Jae Cheol Lee. (2008) A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer. European Journal of Cancer 44:16, 2411-2417
CrossRef188
Ahmad A. Tarhini, John M. Kirkwood, William E. Gooding, Stergios Moschos, Sanjiv S. Agarwala. (2008) A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma. Cancer 113:7, 1632-1640
CrossRef189
G. Gademann, P. Hass. (2008) Strahlentherapeutische Optionen beim Nierenzellkarzinom. Der Onkologe 14:10, 1013-1021
CrossRef190
David W Andrews. (2008) Should surgery followed by whole-brain radiation therapy be the standard treatment for single brain metastasis?. Nature Clinical Practice Oncology 5:10, 572-573
CrossRef191
A. Fowler, R. Cook, M. Biggs, N. Little, N. Assaad, K. McDonald. (2008) Survival of patients following neurosurgical treatment of colorectal adenocarcinoma metastasis in the Northern Sydney–Central Coast area. Journal of Clinical Neuroscience 15:9, 998-1004
CrossRef192
Todd W. Flannery, Mohan Suntharalingam, William F. Regine, Lawrence S. Chin, Mark J. Krasna, Michael K. Shehata, Martin J. Edelman, Marnie Kremer, Roy A. Patchell, Young Kwok. (2008) Long-Term Survival in Patients With Synchronous, Solitary Brain Metastasis From Non–Small-Cell Lung Cancer Treated With Radiosurgery. International Journal of Radiation Oncology*Biology*Physics 72:1, 19-23
CrossRef193
Alberto Franzin, Alberto Vimercati, Piero Picozzi, Carlo Serra, Silvia Snider, Lorenzo Gioia, Camillo Ferrari da Passano, Angelo Bolognesi, Massimo Giovanelli. (2008) Stereotactic drainage and Gamma Knife radiosurgery of cystic brain metastasis. Journal of Neurosurgery 109:2, 259-267
CrossRef194
April F. Eichler, Scott R. Plotkin. (2008) Brain metastases. Current Treatment Options in Neurology 10:4, 308-314
CrossRef195
David N. Church, Ramayana Modgil, Sam Guglani, Amit Bahl, Kirsten Hopkins, Jeremy P. Braybrooke, Peter Blair, Chris G. A. Price. (2008) Extended Survival in Women With Brain Metastases From HER2 Overexpressing Breast Cancer. American Journal of Clinical Oncology 31:3, 250-254
CrossRef196
Se-Hyuk Kim, Samuel T. Chao, Steven A. Toms, Michael A. Vogelbaum, Gene H. Barnett, John H. Suh, Robert J. Weil. (2008) Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma. Surgical Neurology 69:6, 641-646
CrossRef197
Jonathan P.S. Knisely, Brian Berkey, Arnab Chakravarti, Al W.K. Yung, Walter J. Curran, H. Ian Robins, Benjamin Movsas, David G. Brachman, Randall H. Henderson, Minesh P. Mehta. (2008) A Phase III Study of Conventional Radiation Therapy Plus Thalidomide Versus Conventional Radiation Therapy for Multiple Brain Metastases (RTOG 0118). International Journal of Radiation Oncology*Biology*Physics 71:1, 79-86
CrossRef198
Robert R McWilliams, Ravi D Rao, Jan C Buckner, Michael J Link, Svetomir Markovic, Paul D Brown. (2008) Melanoma-induced brain metastases. Expert Review of Anticancer Therapy 8:5, 743-755
CrossRef199
Paul D. Brown, Anthony L. Asher, Elana Farace. (2008) Adjuvant Whole Brain Radiotherapy: Strong Emotions Decide But Rational Studies Are Needed. International Journal of Radiation Oncology*Biology*Physics 70:5, 1305-1309
CrossRef200
Mel Boulton, Mark Bernstein. (2008) Outpatient brain tumor surgery: innovation in surgical neurooncology. Journal of Neurosurgery 108:4, 649-654
CrossRef201
David W. Andrews. (2008) Current Neurosurgical Management of Brain Metastases. Seminars in Oncology 35:2, 100-107
CrossRef202
Dirk Rades, Susanne Kieckebusch, Tiina Haatanen, Radka Lohynska, Juergen Dunst, Steven E. Schild. (2008) Surgical Resection Followed by Whole Brain Radiotherapy Versus Whole Brain Radiotherapy Alone for Single Brain Metastasis. International Journal of Radiation Oncology*Biology*Physics 70:5, 1319-1324
CrossRef203
Steven H Lin, Lawrence R Kleinberg. (2008) Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies. Expert Review of Anticancer Therapy 8:3, 343-359
CrossRef204
W.B. GROWDON, E. LOPEZ-VARELA, R. LITTELL, E. OLIVA, M. SEIDEN, C. KRASNER, H. LEE, A. FULLER. (2008) Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. International Journal of Gynecological Cancer 18:2, 262-268
CrossRef205
S.T. Astner, C. Nieder, A.-L. Grosu, M. Molls. (2008) Strahlentherapie intrazerebraler Metastasen. Der Onkologe 14:3, 246-254
CrossRef206
P. Kiewe, A. Korfel, M. Weller. (2008) Überwindung der Blut-Hirn-Schranke. Der Onkologe 14:3, 260-266
CrossRef207
Fabio M. Iwamoto, Antonio M. Omuro, Jeffrey J. Raizer, Craig P. Nolan, Adília Hormigo, Andrew B. Lassman, Igor T. Gavrilovic, Lauren E. Abrey. (2008) A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases. Journal of Neuro-Oncology 87:1, 85-90
CrossRef208
G. Schackert, J. Felsberg, G. Reifenberger, U. Schlegel. (2008) Hirnmetastasen. Der Onkologe 14:3, 233-245
CrossRef209
Paul W. Sperduto, Brian Berkey, Laurie E. Gaspar, Minesh Mehta, Walter Curran. (2008) A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database. International Journal of Radiation Oncology*Biology*Physics 70:2, 510-514
CrossRef210
Dima Suki, Hiba Abouassi, Akash J. Patel, Raymond Sawaya, Jeffrey S. Weinberg, Morris D. Groves. (2008) Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. Journal of Neurosurgery 108:2, 248-257
CrossRef211
Kazuhiko Ogawa, Yoshihiko Yoshii, Tadashi Nishimaki, Nobumitsu Tamaki, Takao Miyaguni, Yukihiro Tsuchida, Yoshihiko Kamada, Takafumi Toita, Yasumasa Kakinohana, Wakana Tamaki, Shiro Iraha, Genki Adachi, Akio Hyodo, Sadayuki Murayama. (2008) Treatment and prognosis of brain metastases from breast cancer. Journal of Neuro-Oncology 86:2, 231-238
CrossRef212
Atsushi Hiraoka, Norio Horiike, Yohei Koizumi, Nayu Tazuya, Misa Ichiryu, Hiromasa Nakahara, Hironori Ochi, Atsushi Tanabe, Hirokazu Doi, Akihiro Kodama, Aki Hasebe, Soichi Ichikawa, Yasunao Miyamoto, Tomoyuki Ninomiya, Akinori Asagi, Hiroshi Matsubara, Seijin Nadano, Osamu Nishizaki, Masakichi Umeda. (2008) Brain Metastasis from Hepatocellular Carcinoma Treated with a Cyber-Knife. Internal Medicine 47:22, 1993-1996
CrossRef213
Scott G. Soltys, John R. Adler, John D. Lipani, Paul S. Jackson, Clara Y.H. Choi, Putipun Puataweepong, Scarlett White, Iris C. Gibbs, Steven D. Chang. (2008) Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics 70:1, 187-193
CrossRef214
Kadri Altundag, Melissa L. Bondy, Nadeem Q. Mirza, Shu-Wan Kau, Kristine Broglio, Gabriel N. Hortobagyi, Edgardo Rivera. (2007) Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 110:12, 2640-2647
CrossRef215
Dirk Rades, Radka Lohynska, Theo Veninga, Lukas J. A. Stalpers, Steven E. Schild. (2007) Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Cancer 110:11, 2587-2592
CrossRef216
Xiaoyun Cheng, Mien-Chie Hung. (2007) Breast cancer brain metastases. Cancer and Metastasis Reviews 26:3-4, 635-643
CrossRef217
Rupert Bartsch, Andrea Rottenfusser, Catharina Wenzel, Karin Dieckmann, Ursula Pluschnig, Gabriela Altorjai, Margaretha Rudas, Robert M. Mader, Richard Poetter, Christoph C. Zielinski, Guenther G. Steger. (2007) Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer. Journal of Neuro-Oncology 85:3, 311-317
CrossRef218
Michael G. Hart, Robin Grant. 2007. Brain Tumours. , 161-172.
CrossRef219
Jeffrey A Forquer, Matthew Harkenrider, Achilles J Fakiris, Robert D Timmerman, Robert Cavaliere, Mark A Henderson, Simon S Lo. (2007) Brain metastasis from non-seminomatous germ cell tumor of the testis. Expert Review of Anticancer Therapy 7:11, 1567-1580
CrossRef220
Manish Sharma, Jame Abraham. (2007) CNS metastasis in primary breast cancer. Expert Review of Anticancer Therapy 7:11, 1561-1566
CrossRef221
Teri D. Nguyen, Lisa M. DeAngelis. (2007) Brain Metastases. Neurologic Clinics 25:4, 1173-1192
CrossRef222
Volker W. Stieber, Minesh P. Mehta. (2007) Advances in Radiation Therapy for Brain Tumors. Neurologic Clinics 25:4, 1005-1033
CrossRef223
Dirk Rades, Andre Pluemer, Theo Veninga, Juergen Dunst, Steven E. Schild. (2007) A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 110:7, 1551-1559
CrossRef224
J. C. Buckner, P. D. Brown, B. P. O'Neill, F. B. Meyer, C. J. Wetmore, J. H. Uhm. (2007) Central Nervous System Tumors. Mayo Clinic Proceedings 82:10, 1271-1286
CrossRef225
Martin Majer, Wolfram E. Samlowski. (2007) Management of metastatic melanoma patients with brain metastases. Current Oncology Reports 9:5, 411-416
CrossRef226
J.C. Tonn. (2007) Single brain metastasis – What is the role of microsurgery in times of radiosurgery?. European Journal of Cancer Supplements 5:5, 69-71
CrossRef227
Dirk Rades, Steven E. Schild, Radka Lohynska, Theo Veninga, Lukas JA Stalpers, Juergen Dunst. (2007) Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Cancer 110:5, 1077-1082
CrossRef228
G. Schackert. (2007) Aktuelle Therapie von Hirnmetastasen. best practice onkologie 2:4, 4-14
CrossRef229
Eric M. Thompson, Michael D. Sather, Christine A. Reyes, Douglas J. Long. (2007) Intracranial leptomeningeal metastasis from thymic carcinoma: case report and review. Surgical Neurology 68:2, 233-238
CrossRef230
Steven A. Toms, John H. Suh, Robert J. Weil. (2007) Choroid Plexus Metastasis. Urology 70:2, 370-371
CrossRef231
Jan-Peter Hedde, Thomas Neuhaus, Heinrich Schüller, Ute Metzler, Ingo G.H. Schmidt-Wolf, Rolf Kleinschmidt, Christoph Losem, Oliver Lange, Christian Grohe, Sebastian Stier, Yon-Dschun Ko. (2007) A Phase I/II Trial of Topotecan and Radiation Therapy for Brain Metastases in Patients With Solid Tumors. International Journal of Radiation Oncology*Biology*Physics 68:3, 839-844
CrossRef232
Dirk Rades, Guenther Bohlen, Andre Pluemer, Theo Veninga, Patrick Hanssens, Juergen Dunst, Steven E. Schild. (2007) Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 109:12, 2515-2521
CrossRef233
Dima Suki, Frederick F. Lang, Marcos V. C. Maldaun, Hiba Abouassi, Eric L. Chang, Paulo H. P. de Aguiar, Raymond Sawaya. (2007) Complications of Stereotactic Radiosurgery in Patients With Brain Metastases. Neurosurgery Quarterly 17:2, 81-91
CrossRef234
Afshin Forouzannia, Gregory M Richards, Deepak Khuntia, Minesh P Mehta. (2007) Motexafin gadolinium: a novel radiosensitizer for brain tumors. Expert Review of Anticancer Therapy 7:6, 785-794
CrossRef235
Malika L. Siker, Minesh P. Mehta. 2007. Advances in the Treatment of Brain Metastases. , 207-230.
CrossRef236
Teri D. Nguyen, Lauren E. Abrey. (2007) Brain Metastases: Old Problem, New Strategies. Hematology/Oncology Clinics of North America 21:2, 369-388
CrossRef237
RJ Chee, S Bydder, F Cameron. (2007) Prolonged survival after resection and radiotherapy for solitary brain metastases from non-small-cell lung cancer. Australasian Radiology 51:2, 186-189
CrossRef238
Mikhail F. Chernov, Kotaro Nakaya, Masahiro Izawa, Motohiro Hayashi, Yuki Usuba, Koichi Kato, Yoshihiro Muragaki, Hiroshi Iseki, Tomokatsu Hori, Kintomo Takakura. (2007) Outcome After Radiosurgery for Brain Metastases in Patients With Low Karnofsky Performance Scale (KPS) Scores. International Journal of Radiation Oncology*Biology*Physics 67:5, 1492-1498
CrossRef239
Megan Doyle, Nicole Marie Eve Bradley, Kathy Li, Emily Sinclair, Kelvin Lam, Grace Chan, Edward Chow, Elizabeth A. Barnes, Cyril Danjoux, May N. Tsao. (2007) Quality of Life in Patients with Brain Metastases Treated with a Palliative Course of Whole-Brain Radiotherapy. Journal of Palliative Medicine 10:2, 367-374
CrossRef240
Michael L. Smith, John Y. K. Lee. (2007) Stereotactic radiosurgery in the management of brain metastasis. Neurosurgical FOCUS 22:3, 1-8
CrossRef241
Moksha G. Ranasinghe, Jonas M. Sheehan. (2007) Surgical management of brain metastases. Neurosurgical FOCUS 22:3, 1-7
CrossRef242
Sayana R Thomas, Deepak Khuntia. (2007) Motexafi n gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer. International Journal of Nanomedicine 2:1, 79-87
CrossRef243
Elias Dagnew, Jeffrey Kanski, Michael W. McDermott, Penny K. Sneed, Christopher McPherson, John C. Breneman, Ronald E. Warnick. (2007) Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two-institution experience. Neurosurgical FOCUS 22:3, 1-6
CrossRef244
Anthony L. D'Ambrosio, Siviero Agazzi. (2007) Prognosis in patients presenting with brain metastasis from an undiagnosed primary tumor. Neurosurgical FOCUS 22:3, 1-6
CrossRef245
Malika L Siker, Minesh P Mehta. (2007) Resection versus radiosurgery for patients with brain metastases. Future Oncology 3:1, 95-102
CrossRef246
Eric L. Chang, Jeffrey S. Wefel, Moshe H. Maor, Samuel J. Hassenbusch, Anita Mahajan, Frederick F. Lang, Shiao Y. Woo, Leni A. Mathews, Pamela K. Allen, Almon S. Shiu, Christina A. Meyers. (2007) A PILOT STUDY OF NEUROCOGNITIVE FUNCTION IN PATIENTS WITH ONE TO THREE NEW BRAIN METASTASES INITIALLY TREATED WITH STEREOTACTIC RADIOSURGERY ALONE. Neurosurgery 60:2, 277???284
CrossRef247
Joachim M. Baehring, Eudocia Quant, Fred H. Hochberg. 2007. Metastatic Neoplasms and Paraneoplastic Syndromes. , 1081-1101.
CrossRef248
Todd J. Janus, W. K. Alfred Yung. 2007. Primary Neurological Tumors. , 1053-1080.
CrossRef249
Gregory M. Richards, Deepak Khuntia, Minesh P. Mehta. (2007) Therapeutic management of metastatic brain tumors. Critical Reviews in Oncology/Hematology 61:1, 70-78
CrossRef250
J.C. CHURA, K. SHUKLA, P.A. ARGENTA. (2007) Brain metastasis from cervical carcinoma. International Journal of Gynecological Cancer 17:1, 141-146
CrossRef251
S. Buse, J. Bedke, M. Kurosch, A. Haferkamp, A. Unterberg, K. Herfarth, M. Hohenfellner. (2007) Hirnmetastasen beim Nierenzellkarzinom. Der Urologe 46:1, 36-39
CrossRef252
Chris Heyn, John A. Ronald, Soha S. Ramadan, Jonatan A. Snir, Andrea M. Barry, Lisa T. MacKenzie, David J. Mikulis, Diane Palmieri, Julie L. Bronder, Patricia S. Steeg, Toshiyuki Yoneda, Ian C. MacDonald, Ann F. Chambers, Brian K. Rutt, Paula J. Foster. (2006) In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magnetic Resonance in Medicine 56:5, 1001-1010
CrossRef253
Madalina Alexandra Popescu, Steven A Toms. (2006) In vivo optical imaging using quantum dots for the management of brain tumors. Expert Review of Molecular Diagnostics 6:6, 879-890
CrossRef254
Kevin H. Peacock, Glenn J. Lesser. (2006) Current therapeutic approaches in patients with brain metastases. Current Treatment Options in Oncology 7:6, 479-489
CrossRef255
Mikhail F. Chernov, Motohiro Hayashi, Masahiro Izawa, Yuko Ono, Tomokatsu Hori. (2006) Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile. International Journal of Clinical Oncology 11:5, 375-384
CrossRef256
Meili Ma, Jie Shen, Liyan Jiang, Baohui Han, Hao Bai, Hao Ji, Yizuo Zhao, Bo Jin, Yongfeng Yu, Jun Pei, Wei Zhang. (2006) Prognostic factors in patients with stage IV non-small cell lung cancer. The Chinese-German Journal of Clinical Oncology 5:5, 319-323
CrossRef257
Takashi Shuto, Shigeo Inomori, Hideyo Fujino, Hisato Nagano. (2006) Gamma Knife surgery for metastatic brain tumors from renal cell carcinoma. Journal of Neurosurgery 105:4, 555-560
CrossRef258
Fred G. Barker. (2006) Brain metastasis. Journal of Neurosurgery 105:3, 371-372
CrossRef259
Lisa R. Rogers, Jack P. Rock, Allen K. Sills, Michael A. Vogelbaum, John H. Suh, Thomas L. Ellis, Volker W. Stieber, Anthony L. Asher, Robert W. Fraser, Judith S. Billingsley, Paul Lewis, Dawid Schellingerhout, Edward G. Shaw. (2006) Results of a phase II trial of the GliaSite Radiation Therapy System for the treatment of newly diagnosed, resected single brain metastases. Journal of Neurosurgery 105:3, 375-384
CrossRef260
Robert Cavaliere, David Schiff. (2006) Cerebral metastases—a therapeutic update. Nature Clinical Practice Neurology 2:8, 426-436
CrossRef261
Chun Po Yen, Jason Sheehan, Greg Patterson, Ladislau Steiner. (2006) Gamma Knife surgery for metastatic brainstem tumors. Journal of Neurosurgery 105:2, 213-219
CrossRef262
Minh T. Truong, Eric G. St. Clair, Bernadine R. Donahue, Stephen C. Rush, Douglas C. Miller, Silvia C. Formenti, Edmond A. Knopp, Kerry Han, John G. Golfinos. (2006) Results of Surgical Resection for Progression of Brain Metastases Previously Treated by Gamma Knife Radiosurgery. Neurosurgery 59:1, 86-97
CrossRef263
R. Soffietti, P. Cornu, J. Y. Delattre, R. Grant, F. Graus, W. Grisold, J. Heimans, J. Hildebrand, P. Hoskin, M. Kalljo, P. Krauseneck, C. Marosi, T. Siegal, C. Vecht. (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. European Journal of Neurology 13:7, 674-681
CrossRef264
Nicolas Girard, Vincent Cottin, François Tronc, Bénédicte Etienne-Mastroianni, Françoise Thivolet-Bejui, Jérôme Honnorat, Jacques Guyotat, Pierre-Jean Souquet, Jean-François Cordier. (2006) Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastases. Lung Cancer 53:1, 51-58
CrossRef265
Gyorgy T. Szeifert, Dave S. Atteberry, Douglas Kondziolka, Marc Levivier, L. Dade Lunsford. (2006) Cerebral metastases pathology after radiosurgery. Cancer 106:12, 2672-2681
CrossRef266
Timothy Kuo, Lawrence Recht. (2006) Optimizing Therapy for Patients With Brain Metastases. Seminars in Oncology 33:3, 299-306
CrossRef267
Chaosu Hu, Eric L. Chang, Samuel J. Hassenbusch, Pamela K. Allen, Shiao Y. Woo, Anita Mahajan, Ritsuko Komaki, Zhongxing Liao. (2006) Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Cancer 106:9, 1998-2004
CrossRef268
Tania Stafinski, Gian S. Jhangri, Elizabeth Yan, Devidas Menon. (2006) Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: A systematic review and meta-analysis. Cancer Treatment Reviews 32:3, 203-213
CrossRef269
Feng-Ming (Spring) Kong, Lujun Zhao, James A. Hayman. (2006) The Role of Radiation Therapy in Thoracic Tumors. Hematology/Oncology Clinics of North America 20:2, 363-400
CrossRef270
Minh Tam Truong. (2006) Current Role of Radiation Therapy in the Management of Malignant Brain Tumors. Hematology/Oncology Clinics of North America 20:2, 431-453
CrossRef271
A.A. ARGYRIOU, E. CHRONI, P. POLYCHRONOPOULOS, K. ARGYRIOU, S. PAPAPETROPOULOS, M. CORCONDILAS, N. LEPOURA, P. HERAS. (2006) Headache characteristics and brain metastases prediction in cancer patients. European Journal of Cancer Care 15:1, 90-95
CrossRef272
Andrew D Norden, Patrick Y Wen, Santosh Kesari. (2006) Brain metastases. Current Opinion in Internal Medicine 5:1, 42-49
CrossRef273
Doo-Sik Kong, Jung-Il Lee, Do Hyun Nam, Kwan Park, Jong Hyun Kim, Jhin Gook Kim, Jun-O Park, Keunchil Park. (2006) Prognosis of Non-Small Cell Lung Cancer with Synchronous Brain Metastases Treated with Gamma Knife Radiosurgery. Journal of Korean Medical Science 21:3, 527
CrossRef274
Stefanie Milker-Zabel. (2006) Radiosensitizers in Brain Cancer. American Journal of Cancer 5:6, 363-370
CrossRef275
Elizabeth Gore. (2006) Prophylactic Cranial Irradiation Versus Observation in Stage III Non–Small-Cell Lung Cancer. Clinical Lung Cancer 7:4, 276-278
CrossRef276
St??phane Fuentes, Christine Delsanti, Philippe Metellus, Jean Claude Peragut, Fran??ois Grisoli, Jean Regis. (2006) Brainstem Metastases: Management Using Gamma Knife Radiosurgery. Neurosurgery 58:1, 37-42
CrossRef277
Rose Marie Tyson, Dale F Kraemer, Matthew A Hunt, Leslie L Muldoon, Peter Orbay, Leeza Maron, Kristoph Jahnke, Edward A Neuwelt. (2006) The treatment of brain metastasis from breast cancer, role of blood-brain barrier disruption and early experience with trastuzumab. Therapy 3:1, 97-112
CrossRef278
R. Deinsberger, J. Tidstrand. (2006) LINAC Radiosurgery as Single Treatment in Cerebral Metastases. Journal of Neuro-Oncology 76:1, 77-83
CrossRef279
Douglas Kondziolka, Juan J. Martin, John C. Flickinger, David M. Friedland, Adam M. Brufsky, Joseph Baar, Sanjiv Agarwala, John M. Kirkwood, L. Dade Lunsford. (2005) Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104:12, 2784-2791
CrossRef280
Minesh P. Mehta, Deepak Khuntia. (2005) Current Strategies in Whole-brain Radiation Therapy for Brain Metastases. Neurosurgery 57:SUPPLEMENT, S4-33-S4-44
CrossRef281
Allen K. Sills. (2005) Current Treatment Approaches to Surgery for Brain Metastases. Neurosurgery 57:SUPPLEMENT, S4-24-S4-32
CrossRef282
Michael W. McDermott, Penny K. Sneed. (2005) Radiosurgery in Metastatic Brain Cancer. Neurosurgery 57:SUPPLEMENT, S4-45-S4-53
CrossRef283
Matthew G. Ewend, Samer Elbabaa, Lisa A. Carey. (2005) Current Treatment Paradigms for the Management of Patients with Brain Metastases. Neurosurgery 57:SUPPLEMENT, S4-66-S4-77
CrossRef284
David M. Peereboom. (2005) Chemotherapy in Brain Metastases. Neurosurgery 57:SUPPLEMENT, S4-54-S4-65
CrossRef285
Marissa Daniels, Gavin M. Wright. (2005) Complete resection of non-small-cell lung cancer and oligo-metastatic brain disease. ANZ Journal of Surgery 75:11, 963-966
CrossRef286
Carmelo Giannitto Giorgio, Dario Giuffrida, Alessandro Pappalardo, Antonio Russo, Daniele Santini, Placida Salice, Giusy Blanco, Sergio Castorina, Giuseppe Failla, Roberto Bordonaro. (2005) Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II study. Lung Cancer 50:2, 247-254
CrossRef287
Volker W. Stieber, Thomas L. Ellis. (2005) The role of radiosurgery in the management of malignant brain tumors. Current Treatment Options in Oncology 6:6, 501-508
CrossRef288
Evert C. A. Kaal, Martin J. B. Taphoorn, Charles J. Vecht. (2005) Symptomatic management and imaging of brain metastases. Journal of Neuro-Oncology 75:1, 15-20
CrossRef289
Ashok Modha, Scott R. Shepard, Philip H. Gutin. (2005) Surgery of brain metastases – Is there still a place for it?. Journal of Neuro-Oncology 75:1, 21-29
CrossRef290
Robert R McWilliams, Ravi D Rao, Paul D Brown, Michael J Link, Jan C Buckner. (2005) Treatment options for brain metastases from melanoma. Expert Review of Anticancer Therapy 5:5, 809-820
CrossRef291
Robert J. Weil, Diane C. Palmieri, Julie L. Bronder, Andreas M. Stark, Patricia S. Steeg. (2005) Breast Cancer Metastasis to the Central Nervous System. The American Journal of Pathology 167:4, 913-920
CrossRef292
William T. Curry, Garth Rees Cosgrove, Fred H. Hochberg, Jay Loeffler, Nicholas T. Zervas. (2005) Stereotactic interstitial radiosurgery for cerebral metastases. Journal of Neurosurgery 103:4, 630-635
CrossRef293
Lisa J. Hazard, Randy L. Jensen, Dennis C. Shrieve. (2005) Role of Stereotactic Radiosurgery in the Treatment of Brain Metastases. American Journal of Clinical Oncology 28:4, 403-410
CrossRef294
Joachim Pfannschmidt, Bettina Schlolaut, Thomas Muley, Hans Hoffmann, Hendrik Dienemann. (2005) Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer. Lung Cancer 49:2, 203-207
CrossRef295
Alexander Muacevic, Michael Siebels, Jörg-Christian Tonn, Berndt Wowra. (2005) Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery?. World Journal of Urology 23:3, 180-184
CrossRef296
A. Zabel, J. Debus. (2005) Hirnmetastasen. Der Onkologe 11:7, 747-752
CrossRef297
Edward Chow, Lori Davis, Lori Holden, May Tsao, Cyril Danjoux. (2005) Prospective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain Metastases. Journal of Pain and Symptom Management 30:1, 18-23
CrossRef298
Simon S Lo, Eric L Chang, John H Suh. (2005) Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases. Expert Review of Neurotherapeutics 5:4, 487-495
CrossRef299
Olaf Mercier, Elie Fadel, Marc de Perrot, Sacha Mussot, Franco Stella, Alain Chapelier, Philippe Dartevelle. (2005) Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 130:1, 136-140
CrossRef300
Konstantinos S. Polyzoidis, George Miliaras, Nicholas Pavlidis. (2005) Brain metastasis of unknown primary: A diagnostic and therapeutic dilemma. Cancer Treatment Reviews 31:4, 247-255
CrossRef301
John V. Brown, Bram H. Goldstein, Christopher M. Duma, Mark A. Rettenmaier, John P. Micha. (2005) Gamma-knife radiosurgery for the treatment of ovarian cancer metastatic to the brain. Gynecologic Oncology 97:3, 858-861
CrossRef302
May N. Tsao, Nancy S. Lloyd, Rebecca K.S. Wong, Eileen Rakovitch, Edward Chow, Normand Laperriere. (2005) Radiotherapeutic management of brain metastases: A systematic review and meta-analysis. Cancer Treatment Reviews 31:4, 256-273
CrossRef303
L. Chinsoo Cho, Jonathan E. Dowell, Dan Garwood, Ann Spangler, Hak Choy. (2005) Prophylactic Cranial Irradiation With Combined Modality Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer. Seminars in Oncology 32:3, 293-298
CrossRef304
Simon Guo-Jeng Tang, Chen-Kan Tseng, Pei-Kwei Tsay, Chih-Hung Chen, John Wen-Cheng Chang, Ping-Chin Pai, Ji-Hong Hong. (2005) Predictors for patterns of brain relapse and overall survival in patients with non-small cell lung cancer. Journal of Neuro-Oncology 73:2, 153-161
CrossRef305
Renata Duchnowska, Cezary Szczylik. (2005) Central nervous system metastases in breast cancer patients administered trastuzumab. Cancer Treatment Reviews 31:4, 312-318
CrossRef306
Evert CA Kaal, Charles GJH Niël, Charles J Vecht. (2005) Therapeutic management of brain metastasis. The Lancet Neurology 4:5, 289-298
CrossRef307
Catherine R. Tait, Alison Waterworth, Juliette Loncaster, Kieran Horgan, David Dodwell. (2005) The oligometastatic state in breast cancer: hypothesis or reality. The Breast 14:2, 87-93
CrossRef308
Michelle E Melisko, Sandeep Kunwar, Michael Prados, Mitchel S Berger, John W Park. (2005) Brain metastases of breast cancer. Expert Review of Anticancer Therapy 5:2, 253-268
CrossRef309
Giancarlo D’Andrea, Raffaelino Roperto, Lavinia Dinia, Emanuela Caroli, Maurizio Salvati, Luigi Ferrante. (2005) Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases. Neurosurgical Review 28:2, 120-123
CrossRef310
Sara C Erridge, Anna Gregor. (2005) Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases?. Nature Clinical Practice Oncology 2:4, 194-195
CrossRef311
Fred G. Barker. (2005) Surgical and Radiosurgical Management of Brain Metastases. Surgical Clinics of North America 85:2, 329-345
CrossRef312
Blake Cady, Frederick Barker, Alexandra Easson, Albert J. Aboulafia, Peter F. Ferson, Thomas Miner, Abraham Morgentaler. (2005) Part 3: Surgical palliation of advanced illness: What’s new, what’s helpful. Journal of the American College of Surgeons 200:3, 457-466
CrossRef313
Mustafa Aziz Hatiboglu, Murat Cosar, A. Celal Iplikcioglu, Deniz Ozcan. (2005) Brain metastasis from an adenoid cystic carcinoma of the Bartholin gland. Journal of Neurosurgery 102:3, 543-546
CrossRef314
Giacomo G. Vecil, Dima Suki, Marcos V. C. Maldaun, Frederick F. Lang, Raymond SaWaya. (2005) Resection of brain metastases previously treated with stereotactic radiosurgery. Journal of Neurosurgery 102:2, 209-215
CrossRef315
Tatsuro Okamoto, Riichiroh Maruyama, Fumihiro Shoji, Hiroshi Asoh, Jiro Ikeda, Tetsuya Miyamoto, Tomomi Nakamura, Tetsuro Miyake, Yukito Ichinose. (2005) Long-term survivors in stage IV non-small cell lung cancer. Lung Cancer 47:1, 85-91
CrossRef316
Luna Ghosh, William Dahut, Sanjay Kakar, Edwin M. Posadas, Camilo G. Torres, Rosemary Cancel-Santiago, Bimal C. Ghosh. (2005) Management of patients with metastatic cancer of unknown primary. Current Problems in Surgery 42:1, 12-66
CrossRef317
L. O'Toole, N. Charnley, G.E. Gerrard. (2004) Management of solitary brain metastases. Clinical Oncology 16:8, 580
CrossRef318
Alicia Tosoni, Mario Ermani, Alba A. Brandes. (2004) The pathogenesis and treatment of brain metastases: a comprehensive review. Critical Reviews in Oncology/Hematology 52:3, 199-215
CrossRef319
Jay S Loeffler. (2004) Can combined whole brain radiation therapy and radiosurgery improve the treatment of single brain metastases?. Nature Clinical Practice Oncology 1:1, 12-13
CrossRef320
David G Kirsch, Jay S Loeffler. (2004) Treating brain metastases: current approaches and future directions. Expert Review of Neurotherapeutics 4:6, 1015-1022
CrossRef321
Arthur J. Ulm, William A. Friedman, Frank J. Bova, Patrick Bradshaw, Robert J. Amdur, William M. Mendenhall. (2004) Linear Accelerator Radiosurgery in the Treatment of Brain Metastases. Neurosurgery 55:5, 1076-1085
CrossRef322
Michael G Hart, Robert Grant, Mark Walker, Heather O Dickinson, Robin Grant. 2004. Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases. .
CrossRef323
Kristin A. Bradley, Minesh P. Mehta. (2004) Management of brain metastases. Seminars in Oncology 31:5, 693-701
CrossRef324
Alicia Tosoni, Franco Lumachi, Alba A Brandes. (2004) Treatment of brain metastases in uncommon tumors. Expert Review of Anticancer Therapy 4:5, 783-793
CrossRef325
William F. Regine, Anna Rogozinska, Richard J. Kryscio, Phillip A. Tibbs, A Byron Young, Roy A. Patchell. (2004) Recursive Partitioning Analysis Classifications I and II. American Journal of Clinical Oncology 27:5, 505-509
CrossRef326
Jay Jagannathan, Joshua H. Petit, Karl Balsara, Richard Hudes, Lawrence S. Chin. (2004) Long-Term Survival After Gamma Knife Radiosurgery for Primary and Metastatic Brain Tumors. American Journal of Clinical Oncology 27:5, 441-444
CrossRef327
Wolfgang Schuette. (2004) Treatment of brain metastases from lung cancer: chemotherapy. Lung Cancer 45, S253-S257
CrossRef328
Ratna Datta, Ajay Jawahar, Federico L. Ampil, Runhua Shi, Anil Nanda, Horacio DʼAgostino. (2004) Survival in Relation to Radiotherapeutic Modality for Brain Metastasis. American Journal of Clinical Oncology 27:4, 420-424
CrossRef329
Angelika Zabel, Jürgen Debus. (2004) Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy. Lung Cancer 45, S247-S252
CrossRef330
Narendra Nathoo, Steven A Toms, Gene H Barnett. (2004) Metastases to the brain: current management perspectives. Expert Review of Neurotherapeutics 4:4, 633-640
CrossRef331
Suriya A. Jeyapalan, Tracy Batchelor. (2004) Management of brain metastases. Current Treatment Options in Neurology 6:4, 273-284
CrossRef332
L. C. Lim, M. A. Rosenthal, N. Maartens, G. Ryan. (2004) Management of brain metastases. Internal Medicine Journal 34:5, 270-278
CrossRef333
S. Tangjitgamol, C. F. Levenback, U. Beller, J. J. Kavanagh. (2004) Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. International Journal of Gynecological Cancer 14:3, 399-422
CrossRef334
Antonio Marcilio Padula Omuro, Lauren Eileen Abrey. (2004) Brain metastases. Current Neurology and Neuroscience Reports 4:3, 205-210
CrossRef335
David W Andrews, Charles B Scott, Paul W Sperduto, Adam E Flanders, Laurie E Gaspar, Michael C Schell, Maria Werner-Wasik, William Demas, Janice Ryu, Jean-Paul Bahary, Luis Souhami, Marvin Rotman, Minesh P Mehta, Walter J Curran. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. The Lancet 363:9422, 1665
CrossRef336
Tracy E. Kim, John R. Murren. (2004) Therapy for Stage IIIA, IIIB and IV Non???Small Cell Lung Cancer. Clinical Pulmonary Medicine 11:3, 161-174
CrossRef337
Kathryn Spanknebel, Howard L. Kaufman. (2004) Surgical treatment of stage IV melanoma. Clinics in Dermatology 22:3, 240-250
CrossRef338
Allan Y. Chen, Rachel Chou, Shyh-Jen Shih, Derick Lau, David Gandara. (2004) Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs. Critical Reviews in Oncology/Hematology 50:2, 111-119
CrossRef339
Alexander Muacevic, Friedrich W. Kreth, J
rg-Christian Tonn, Berndt Wowra. (2004) Stereotactic radiosurgery for multiple brain metastases from breast carcinoma. Cancer 100:8, 1705-1711
CrossRef340
Laurie E Gaspar. (2004) Brain metastases in lung cancer. Expert Review of Anticancer Therapy 4:2, 259-270
CrossRef341
Branislav Jeremic. (2004) Radiation therapy in small cell lung cancer. Hematology/Oncology Clinics of North America 18:2, 297-307
CrossRef342
N.S Vasudev, B.A Cross, M Snee, J.K Joffe. (2004) Aggressive Management of Non-small Cell Lung Cancer with Synchronous Solitary Brain Metastasis. Clinical Oncology 16:2, 158-159
CrossRef343
Ahmad A Tarhini, Sanjiv S Agarwala. (2004) Management of brain metastases in patients with melanoma. Current Opinion in Oncology 16:2, 161-166
CrossRef344
Ajay Jawahar, Federico Ampil, Christina Wielbaecher, Golda H. Hartman, John H. Zhang, Anil Nanda. (2004) Management Strategies for Patients with Brain Metastases: Has Radiosurgery Made a Difference?. Southern Medical Journal 97:3, 254-258
CrossRef345
R.Allan Purdy, Sarah Kirby. (2004) Headaches and brain tumors. Neurologic Clinics 22:1, 39-53
CrossRef346
Julie Sandruck, Pedro Escobar, John Lurain, David Fishman. (2004) Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature. Gynecologic Oncology 92:2, 701-704
CrossRef347
Wood, Alastair J.J., , Spira, Alexander, Ettinger, David S., . (2004) Multidisciplinary Management of Lung Cancer. New England Journal of Medicine 350:4, 379-392
Full Text348
Kevin J. Klos, Brian Patrick O’Neill. (2004) Brain Metastases. The Neurologist 10:1, 31-46
CrossRef349
Georges Noel, Charles-Ambroise Valery, Gilbert Boisserie, Philippe Cornu, Dominique Hasboun, Jean Marc Simon, Bernadette Tep, Dominique Ledu, Jean-Yves Delattre, Claude Marsault, François Baillet, Jean-Jacques Mazeron. (2004) LINAC radiosurgery for brain metastasis of renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations 22:1, 25-31
CrossRef350
Roy A Patchell. (2003) The management of brain metastases. Cancer Treatment Reviews 29:6, 533-540
CrossRef351
Gabriela Simonová, Liscák Roman. (2003) Radiosurgery in the treatment of malignant brain tumors. Expert Review of Anticancer Therapy 3:6, 879-890
CrossRef352
R. R. McWilliams, P. D. Brown, J. C. Buckner, M. J. Link, S. N. Markovic. (2003) Treatment of Brain Metastases From Melanoma. Mayo Clinic Proceedings 78:12, 1529-1536
CrossRef353
M.M.H. Hochstenbag, A. Twijnstra, P. Hofman, E.F.M. Wouters, G.P.M. ten Velde. (2003) MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment?. Lung Cancer 42:2, 189-193
CrossRef354
M.N. Tsao, K. Sultanem, D. Chiu, F. Copps, P. Dixon, D. Easton¶, P. Haddad, C. Hayter, D. Hoegler
, R. Wong. (2003) Supportive Care Management of Brain Metastases: What is Known and What We Need to Know. Clinical Oncology 15:7, 429-434
CrossRef355
G VECIL, F LANG. (2003) Surgical resection of metastatic intraventricular tumors. Neurosurgery Clinics of North America 14:4, 593-606
CrossRef356
Georges Noel, Jacques Medioni, Charles-Ambroise Valery, Gilbert Boisserie, Jean Marc Simon, Philippe Cornu, Dominique Hasboun, Dominique Ledu, Bernadette Tep, Jean-Yves Delattre, Claude Marsault, François Baillet, Jean-Jacques Mazeron. (2003) Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer 41:3, 333-343
CrossRef357
Jason Sheehan, Douglas Kondziolka, John Flickinger, L. Dade Lunsford. (2003) Radiosurgery for Patients With Metastasis to the Brain. Techniques in Neurosurgery 9:3, 152-160
CrossRef358
Edward Rustamzadeh, Walter C. Low, Daniel A. Vallera, Walter A. Hall. (2003) Immunotoxin therapy for CNS tumor. Journal of Neuro-oncology 64:1-2, 101-116
CrossRef359
Sadaf Taimur, Martin J. Edelman. (2003) Treatment options for brain metastases in patients with non-small-cell lung cancer. Current Oncology Reports 5:4, 342-346
CrossRef360
Eric L. Chang, Samuel J. Hassenbusch, Almon S. Shiu, Frederick F. Lang, Pamela K. Allen, Raymond Sawaya, Moshe H. Maor. (2003) The Role of Tumor Size in the Radiosurgical Management of Patients with Ambiguous Brain Metastases. Neurosurgery 53:2, 272-281
CrossRef361
Tze-Ching Tan, Peter McL. Black. (2003) Image-guided Craniotomy for Cerebral Metastases: Techniques and Outcomes. Neurosurgery 53:1, 82-90
CrossRef362
Toshinori Hasegawa, Douglas Kondziolka, John C. Flickinger, Anand Germanwala, L. Dade Lunsford. (2003) Brain Metastases Treated with Radiosurgery Alone: An Alternative to Whole Brain Radiotherapy?. Neurosurgery 52:6, 1318-1326
CrossRef363
Sang-wook Lee, Eun Kyung Choi, Heon Joo Park, Seung Do Ahn, Jong Hoon Kim, Kyung Ju Kim, Sang Min Yoon, Young Seok Kim, Byong Yong Yi. (2003) Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40:3, 309-315
CrossRef364
Johannes Lutterbach, Donatus Cyron, Karl Henne, Christoph B. Ostertag. (2003) Radiosurgery Followed by Planned Observation in Patients with One to Three Brain Metastases. Neurosurgery 52:5, 1066-1074
CrossRef365
Massimo Gerosa, Antonio Nicolato, Roberto Foroni. (2003) The role of gamma knife radiosurgery in the treatment of primary and metastatic brain tumors. Current Opinion in Oncology 15:3, 188-196
CrossRef366
J. Oertel, M.R. Gaab, J. Piek. (2003) Waterjet resection of brain metastases – first clinical results with 10 patients. European Journal of Surgical Oncology (EJSO) 29:4, 407-414
CrossRef367
Gennaro Cormio, Andrea Maneo, Antonio Colamaria, Giuseppe Loverro, Andrea Lissoni, Luigi Selvaggi. (2003) Surgical resection of solitary brain metastasis from ovarian carcinoma. Gynecologic Oncology 89:1, 116-119
CrossRef368
Hamisi Kimaro Shabani, Gaspar Kitange, Keishi Tsunoda, Takeo Anda, Yoshiharu Tokunaga, Shobu Shibata, Makio Kaminogo, Tomayoshi Hayashi, H. Ayabe, Masachika Iseki. (2003) Immunohistochemical expression of E-cadherin in metastatic brain tumors. Brain Tumor Pathology 20:1, 7-12
CrossRef369
Patrick Y Wen, David Schiff. (2003) Neurologic complications of solid tumors. Neurologic Clinics 21:1, 107-140
CrossRef370
Jason P. Sheehan, Ming-Hsi Sun, Douglas Kondziolka, John Flickinger, L. Dade Lunsford. (2003) Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. Journal of Neurosurgery 98:2, 342-349
CrossRef371
Andrew B Lassman, Lisa M DeAngelis. (2003) Brain metastases. Neurologic Clinics 21:1, 1-23
CrossRef372
Richard Essner. (2003) Surgical treatment of malignant melanoma. Surgical Clinics of North America 83:1, 109-156
CrossRef373
Romney J.E Pope, David M Hansell. (2003) Extra-thoracic staging of lung cancer. European Journal of Radiology 45:1, 31-38
CrossRef374
Matthew J. Schuchert, James D. Luketich. (2003) Solitary sites of metastatic disease in non-small cell lung cancer. Current Treatment Options in Oncology 4:1, 65-79
CrossRef375
Scott R. Plotkin, Patrick Y. Wen. 2003. Brain Metastases. , 1101-1107.
CrossRef376
Sadaf Taimur, Martin J. Edelman. (2003) Treatment options for brain metastases in patients with non-small cell lung cancer. Current Treatment Options in Oncology 4:1, 89-95
CrossRef377
Michael L. Gruber. 2003. Neurologic Complications of Lung Cancer. , 1178-1181.
CrossRef378
Roy A. Patchell. 2003. Metastases, Brain. , 128-134.
CrossRef379
Daniel E Roos, Brian P Brophy, Sergei F Zavgorodni, Evangelos S Katsilis. (2002) Radiosurgery for brain metastases at the Royal Adelaide Hospital: Are we treating the right patients?. Australasian Radiology 46:4, 402-408
CrossRef380
Jason P. Sheehan, Ming-Hsi Sun, Douglas Kondziolka, John Flickinger, L. Dade Lunsford. (2002) Radiosurgery for non—small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. Journal of Neurosurgery 97:6, 1276-1281
CrossRef381
James G Douglas, Kim Margolin. (2002) The treatment of brain metastases from malignant melanoma. Seminars in Oncology 29:5, 518-524
CrossRef382
Berndt Wowra, Michael Siebels, Alexander Muacevic, Friedrich Wilhelm Kreth, Andreas Mack, Alfons Hofstetter. (2002) Repeated gamma knife surgery for multiple brain metastases from renal cell carcinoma. Journal of Neurosurgery 97:4, 785-793
CrossRef383
Paul D. Brown, Cerise A. Brown, Bruce E. Pollock, Deborah A. Gorman, Robert L. Foote. (2002) Stereotactic Radiosurgery for Patients with “Radioresistant” Brain Metastases. Neurosurgery 51:3, 656-667
CrossRef384
RON SWENSEN, WOLFF KIRSCH. (2002) Brain Neoplasms in Women: A Review. Clinical Obstetrics and Gynecology 45:3, 904-927
CrossRef385
Paul D. Brown, Cerise A. Brown, Bruce E. Pollock, Deborah A. Gorman, Robert L. Foote. (2002) Stereotactic Radiosurgery for Patients with ???Radioresistant??? Brain Metastases. Neurosurgery 51:3, 656-667
CrossRef386
A Sanderson, S.C Bonington, B.M Carrington, D.L Alison, J.A Spencer. (2002) Cerebral Metastasis and other Cerebral Events in Women with Ovarian Cancer. Clinical Radiology 57:9, 815-819
CrossRef387
MN Tsao, E Chow, R Wong, E Rakovitch, N Laperriere, May Tsao. 2002. Whole brain radiotherapy for the treatment of multiple brain metastases. .
CrossRef388
Angelika Zabel, Stefanie Milker-Zabel, Christoph Thilmann, Ivan Zuna, Bernhard Rhein, Michael Wannenmacher, Jürgen Debus. (2002) Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors. Lung Cancer 37:1, 87-94
CrossRef389
Kimihiro Shimizu, Kanji Nagai, Junji Yoshida, Mituyo Nishimura, Ryuichi Hayashi, Tomoyuki Yokose. (2002) Successful management of solitary malar metastasis from lung cancer. Lung Cancer 36:3, 337-339
CrossRef390
Steven J. DiBiase, Lawrence S. Chin, Lijun Ma. (2002) Influence of Gamma Knife Radiosurgery on the Quality of Life in Patients With Brain Metastases. American Journal of Clinical Oncology 25:2, 131-134
CrossRef391
Maria H. Christiaans, Johannes C. Kelder, Edo P. J. Arnoldus, Cees C. Tijssen. (2002) Prediction of intracranial metastases in cancer patients with headache. Cancer 94:7, 2063-2068
CrossRef392
Tracy E Kim, John R Murren. (2002) Therapy for stage IIIB and stage IV non-small cell lung cancer. Clinics in Chest Medicine 23:1, 209-224
CrossRef393
Andrew C. Zacest, Michael Besser, Graham Stevens, John F. Thompson, William H. McCarthy, Gordana Culjak. (2002) Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. Journal of Neurosurgery 96:3, 552-558
CrossRef394
Vincenzo Mingione, Marcelo Oliveira, Dheerendra Prasad, Melita Steiner, Ladislau Steiner. (2002) Gamma surgery for melanoma metastases in the brain. Journal of Neurosurgery 96:3, 544-551
CrossRef395
Michael Brada, Tina Foord. (2002) Radiosurgery for Brain Metastases. Clinical Oncology 14:1, 28-30
CrossRef396
Kazuhiko Ogawa, Takafumi Toita, Hiroo Sueyama, Nobukazu Fuwa, Yasumasa Kakinohana, Minoru Kamata, Genki Adachi, Atsushi Saito, Yoshihiko Yoshii, Sadayuki Murayama. (2002) Brain metastases from esophageal carcinoma. Cancer 94:3, 759-764
CrossRef397
Majdi M. Abdel-Raheem, Anil Potti, William K. Becker, Akiko Saberi, Bradley S. Scilley, Syed A. Mehdi. (2002) Late Adrenal Metastasis in Operable Non–Small-Cell Lung Carcinoma. American Journal of Clinical Oncology 25:1, 81-83
CrossRef398
D.L.L. Roberts, A.V. Anstey, R.J. Barlow, N.H. Cox, , J.A. Newton Bishop, P.G. Corrie, J. Evans, M.E. Gore, P.N. Hall, N. Kirkham. (2002) U.K. guidelines for the management of cutaneous melanoma. British Journal of Dermatology 146:1, 7-17
CrossRef399
Yoshiya Yamada. 2002. Stereotactic Radiosurgery of Intracranial Neoplasms. , 265-273.
CrossRef400
John C. Flickinger. (2001) Radiotherapy and radiosurgical management of brain metastases. Current Oncology Reports 3:6, 484-489
CrossRef401
Eduardo Weltman, João Victor Salvajoli, Reynaldo André Brandt, Rodrigo de Morais Hanriot, Flavio Eduardo Prisco, José Carlos Cruz, Sandra Regina de Oliveira Borges, Monica Lagatta, Dália Ballas Wajsbrot. (2001) Radiosurgery for brain metastases: who may not benefit?. International Journal of Radiation Oncology*Biology*Physics 51:5, 1320-1327
CrossRef402
Martin J. van den Bent. (2001) The diagnosis and management of brain metastases. Current Opinion in Neurology 14:6, 717-723
CrossRef403
Susanne M. Arnold, Roy A. Patchell. (2001) DIAGNOSIS AND MANAGEMENT OF BRAIN METASTASES. Hematology/Oncology Clinics of North America 15:6, 1085-1108
CrossRef404
Jeffrey S. Weinberg, Frederick F. Lang, Raymond Sawaya. (2001) Surgical management of brain metastases. Current Oncology Reports 3:6, 476-483
CrossRef405
Ashraf S. Mahmoud-Ahmed, John H. Suh, Gene H. Barnett, Kenneth D. Webster, Jerome L. Belinson, Alexander W. Kennedy. (2001) The Effect of Radiation Therapy on Brain Metastases from Endometrial Carcinoma: A Retrospective Study. Gynecologic Oncology 83:2, 305-309
CrossRef406
Matthew G. Ewend, Lisa A. Carey, David E. Morris, R. Donald Harvey, Thomas A. Hensing. (2001) Brain metastases. Current Treatment Options in Oncology 2:6, 537-547
CrossRef407
R Grant, M Walker. 2001. Surgical resection and whole brain radiation therapy versus whole brain radiation therapy for solitary brain metastases. .
CrossRef408
Thomas A D’Amico, Thomas A Aloia, Mary-Beth H Moore, Debbi H Conlon, James E Herndon, Michael S Kinch, David H Harpole. (2001) Predicting the sites of metastases from lung cancer using molecular biologic markers. The Annals of Thoracic Surgery 72:4, 1144-1148
CrossRef409
John M. Abrahams, Maria Torchia, Mary Putt, Larry R. Kaiser, Kevin D. Judy. (2001) Risk factors affecting survival after brain metastases from non—small cell lung carcinoma: a follow-up study of 70 patients. Journal of Neurosurgery 95:4, 595-600
CrossRef410
Nicolas Penel, Anne Brichet, Bernard Prevost, Alain Duhamel, Richard Assaker, François Dubois, Jean-Jacques Lafitte. (2001) Pronostic factors of synchronous brain metastases from lung cancer. Lung Cancer 33:2-3, 143-154
CrossRef411
R. Jyothirmayi, F.H. Saran, R. Jalali, J. Perks, A.P. Warrington, D. Traish, S. Ashley, F. Hines, M. Brada. (2001) Stereotactic Radiotherapy for Solitary Brain Metastases. Clinical Oncology 13:3, 228-234
CrossRef412
Ashraf S. Mahmoud-Ahmed, John H. Suh, Gene H. Barnett, Kenneth D. Webster, Alexander W. Kennedy. (2001) Tumor Distribution and Survival in Six Patients with Brain Metastases from Cervical Carcinoma. Gynecologic Oncology 81:2, 196-200
CrossRef413
Patrick Rodrigus, Peter de Brouwer, Esther Raaymakers. (2001) Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation. Lung Cancer 32:2, 129-136
CrossRef414
Y. Marcou, C. Lindquist, C. Adams, S. Retsas, P.N. Plowman. (2001) What is the Optimal Therapy of Brain Metastases?. Clinical Oncology 13:2, 105-111
CrossRef415
Christina M. Marciniak, James A. Sliwa, Allen W. Heinemann, Patrick E. Semik. (2001) Functional outcomes of persons with brain tumors after inpatient rehabilitation. Archives of Physical Medicine and Rehabilitation 82:4, 457-463
CrossRef416
S SMITH, W KOH. (2001) Palliative radiation therapy for gynaecological malignancies. Best Practice & Research Clinical Obstetrics & Gynaecology 15:2, 265-278
CrossRef417
Henri Porte, Joëlle Siat, Benoit Guibert, Francoise Lepimpec-Barthes, René Jancovici, Alain Bernard, Annick Foucart, Alain Wurtz. (2001) Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. The Annals of Thoracic Surgery 71:3, 981-985
CrossRef418
David Schiff. (2001) Single brain metastasis. Current Treatment Options in Neurology 3:1, 89-99
CrossRef419
Francesco Grossi, Tindaro Scolaro, Lucia Tixi, Maura Loprevite, Andrea Ardizzoni. (2001) The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer. Critical Reviews in Oncology/Hematology 37:1, 61-67
CrossRef420
Frank Lohr, Andrea Pirzkall, Holger Hof, Katharina Fleckenstein, J
CrossRef421
Carsten Nieder, Ursula Nestle, Karin Walter, Marcus Niewald, Klaus Schnabel. (2000) Dose–Response Relationships for Radiotherapy of Brain Metastases. American Journal of Clinical Oncology: Cancer Clinical Trials 23:6, 584-588
CrossRef422
Jack P. Rock, Stephen Haines, Lawrence Recht, Mark Bernstein, Raymond Sawaya, Tom Mikkelsen, Jay Loeffler. (2000) Practice parameters for the management of single brain metastasis. Neurosurgical FOCUS 9:6, 1-9
CrossRef423
Patrick Y. Wen, Jay S. Loeffler. (2000) Brain metastases. Current Treatment Options in Oncology 1:5, 447-457
CrossRef424
Douglas Kondziolka, Atul Patel, L. Dade Lunsford, John C. Flickinger. (2000) Decision making for patients with multiple brain metastases: radiosurgery, radiotherapy, or resection?. Neurosurgical FOCUS 9:2, 1-6
CrossRef425
Dimitri A Christakis, Sanjay Saint, Somnath Saha, Joann G Elmore, Deborah E Welsh, Paul Baker, Thomas D Koepsell. (2000) Do physicians judge a study by its cover?. Journal of Clinical Epidemiology 53:8, 773-778
CrossRef426
WA Hall, HR Djalilian, ES Nussbaum, KH Cho. (2000) Long-term survival with metastatic cancer to the brain. Medical Oncology 17:4, 279-286
CrossRef427
Kwan H. Cho, Walter A. Hall, Bruce J. Gerbi, Patrick D. Higgins. (2000) The role of radiosurgery for multiple brain metastases. Neurosurgical FOCUS 9:2, 1-7
CrossRef428
Joseph C. T. Chen, Zbigniew Petrovich, Steven O???Day, Donald Morton, Richard Essner, Steven L. Giannotta, Cheng Yu, Michael L. J. Apuzzo. (2000) Stereotactic Radiosurgery in the Treatment of Metastatic Disease to the Brain. Neurosurgery 47:2, 268-281
CrossRef429
Tone Fokstuen, Nils Wilking, Lars Erik Rutqvist, Jeanette Wolke, Anette Liedberg, Toom Signomklao, Jan-Olof Fernberg. (2000) Radiation therapy in the management of brain metastases from breast cancer. Breast Cancer Research and Treatment 62:3, 211-216
CrossRef430
Moshe H. Maor, Praveen Dubey, Susan L. Tucker, Almon S. Shiu, Brian N. Mathur, Raymond Sawaya, Frederick F. Lang, Samuel J. Hassenbusch. (2000) Stereotactic radiosurgery for brain metastases:Results and prognostic factors. International Journal of Cancer 90:3, 157-162
CrossRef431
Ajay Niranjan, L. Dade Lunsford, Glenn T. Gobbel, Douglas Kondziolka, Ann Maitz, John C. Flickinger. (2000) Brain tumor radiosurgery: current status and strategies to enhance the effect of radiosurgery. Brain Tumor Pathology 17:2, 89-96
CrossRef432
Wayne S. Kendal. (2000) Fractal heterogeneity of peripheral blood flow: Implications for hematogenous metastases. Journal of Surgical Oncology 74:2, 116-121
CrossRef433
Bernard J. Park, Otway Louie, Nasser Altorki. (2000) STAGING AND THE SURGICAL MANAGEMENT OF LUNG CANCER. Radiologic Clinics of North America 38:3, 545-561
CrossRef434
Baosheng Li, Jinming Yu, Mohan Suntharalingam, Andrew S. Kennedy, Pradip P. Amin, Zhengqian Chen, Rong Yin, Shoufang Guo, Tingmang Han, Yabin Wang, Ningsha Yu, Guangde Song, Liying Wang. (2000) Comparison of three treatment options for single brain metastasis from lung cancer. International Journal of Cancer 90:1, 37-45
CrossRef435
William A Friedman, Kelly D Foote. (2000) Linear accelerator radiosurgery in the management of brain tumours. Annals of Medicine 32:1, 64-80
CrossRef436
Lisa M. DeAngelis. (1999) Metastatic disease of the nervous system. Current Treatment Options in Neurology 1:5, 409-416
CrossRef437
Ian E. McCutcheon, David Y. Eng, Christopher J. Logothetis. (1999) Brain metastasis from prostate carcinoma. Cancer 86:11, 2301-2311
CrossRef438
Charles H. Cha, Gregory D. Kennedy, John E. Niederhuber. (1999) METASTATIC BREAST CANCER. Surgical Clinics of North America 79:5, 1117-1143
CrossRef439
Chuan-Fu Huang, Douglas Kondziolka, John C. Flickinger, L. Dade Lunsford. (1999) Stereotactic radiosurgery for brainstem metastases. Journal of Neurosurgery 91:4, 563-568
CrossRef440
Sudha Parasuraman, James Langston, Bhaskar N. Rao, Catherine A. Poquette, Jesse J. Jenkins, Thomas Merchant, Alvida Cain, Charles B. Pratt, Alberto S. Pappo. (1999) Brain Metastases in Pediatric Ewing Sarcoma and Rhabdomyosarcoma. Journal of Pediatric Hematology/Oncology 21:5, 370-377
CrossRef441
Naresh C. Gupta, Peter Nicholson, Stephen M. Bloomfield. (1999) FDG-PET in the Staging Work-Up of Patients with Suspected Intracranial Metastatic Tumors. Annals of Surgery 230:2, 202
CrossRef442
C.R. Lewanski, N. Botwood, M.G. Glaser. (1999) Bilateral Cerebellopontine Metastases in a Patient with an Unknown Primary. Clinical Oncology 11:4, 272-273
CrossRef443
Alexander Muacevic, Friedrich W. Kreth, Gerhard A. Horstmann, Robert Schmid-Elsaesser, Berndt Wowra, Hans J. Steiger, Hans J. Reulen. (1999) Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary single cerebral metastases of small diameter. Journal of Neurosurgery 91:1, 35-43
CrossRef444
John H. Suh, Gene H. Barnett. (1999) BRACHYTHERAPY FOR BRAIN TUMOR. Hematology/Oncology Clinics of North America 13:3, 635-650
CrossRef445
B. Todd Heniford, Marjorie J. Arca, R. Matthew Walsh, Inderbir S. Gill. (1999) Laparoscopic adrenalectomy for cancer. Seminars in Surgical Oncology 16:4, 293-306
CrossRef446
Cesar V. Reyes, Karen Sue Thompson, JoAnne D. Jensen. (1999) Cytopathologic evaluation of lung carcinomas presenting as brain metastasis. Diagnostic Cytopathology 20:6, 325-327
CrossRef447
Benjamin W. Corn, Minesh P. Mehta, John M. Buatti, Aaron H. Wolfson, Kathryn M. Greven, Robert Y. Kim, Charles J. Dunton, Jay S. Loeffler. (1999) Stereotactic Irradiation. American Journal of Clinical Oncology 22:2, 143-146
CrossRef448
C Lebrun, M Frenay, M Lonjon, P.Y Marcy, P Grellier. (1999) Métastases cérébrales et chimiothérapie. La Revue de Médecine Interne 20:3, 247-252
CrossRef449
Jürgen Debus, Andrea Pirzkall, Wolfgang Schlegel, Michael Wannenmacher. (1999) Stereotaktische einzeitbestrahlung (radiochirurgie) Methodik, indikationen, ergebnisse. Strahlentherapie und Onkologie 175:2, 47-56
CrossRef450
Mark A. Chidel, John H. Suh, John F. Greskovich, Patrick A. Kupelian, Gene H. Barnett. (1999) Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis. Radiation Oncology Investigations 7:5, 313-319
CrossRef451
Michael D. Taylor, Mark Bernstein. (1999) Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. Journal of Neurosurgery 90:1, 35-41
CrossRef452
B E Pollock, D A Gorman, P J Schomberg, R W Kline. (1999) The Mayo Clinic gamma knife experience: indications and initial results.. Mayo Clinic Proceedings 74:1, 5-13
CrossRef453
Matthew G. Ewend, Prakash Sampath, Jeffery A. Williams, Betty M. Tyler, Henry Brem. (1998) Local Delivery of Chemotherapy Prolongs Survival in Experimental Brain Metastases from Breast Carcinoma. Neurosurgery 43:5, 1185-1192
CrossRef454
Christopher S. Rumana, Kenneth R. Hess, Wei Ming Shi, Raymond Sawaya. (1998) Metastatic brain tumors with dural extension. Journal of Neurosurgery 89:4, 552-558
CrossRef455
Rosa M. Martı́nez-Mañas, Marta Brell, Jordi Rumià, Enrique Ferrer. (1998) Brain Metastases in Endometrial Carcinoma. Gynecologic Oncology 70:2, 282-284
CrossRef456
Deborah T. Blumenthal, Lisa M. DeAngelis. (1998) AGING AND PRIMARY CENTRAL NERVOUS SYSTEM NEOPLASMS. Neurologic Clinics 16:3, 671-686
CrossRef457
V VENDRELY, L PRIE, A BENYOUCEF, A CHEMIN, G KANTOR. (1998) Radiochirurgie de métastase cérébrale unique sans irradiation cérébrale totale associée. Résultats d'une série consécutive de 12 cas. Cancer/Radiothérapie 2:4, 375-380
CrossRef458
C. BENDINELLI, M. LUCCHI, P. BUCCIANTI, P. IACCONI, C.A. ANGELETTI, P. MICCOLI. (1998) Adrenal Masses in Non-Small Cell Lung Carcinoma Patients: Is There Any Role for Laparoscopic Procedures?. Journal of Laparoendoscopic & Advanced Surgical Techniques 8:3, 119-124
CrossRef459
Terry Bunston, Deborah Mings, Normand Laperriere, Jacquey Malcolm, Dorothy Williams. (1998) The impact of psychosocial need and needs resolution on quality of life in patients with brain tumors. Neurosurgical FOCUS 4:6, E9
CrossRef460
Joseph Bampoe, Paul Ritvo, Mark Bernstein. (1998) Quality of life in patients with brain tumor: what's relevant in our quest for therapeutic efficacy. Neurosurgical FOCUS 4:6, E8
CrossRef461
V Minotti, L Crino′, M.L Meacci, E Corgna, S Darwish, M.A Palladino, M Betti, M Tonato. (1998) Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer. Lung Cancer 20:2, 93-98
CrossRef462
David Schiff, Tracy Batchelor, Patrick Y. Wen. (1998) NEUROLOGIC EMERGENCIES IN CANCER PATIENTS. Neurologic Clinics 16:2, 449-483
CrossRef463
Karen Kelly, Paul A Bunn. (1998) Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?. Lung Cancer 20:2, 85-91
CrossRef464
L FEUVRET, I GERMAIN, P CORNU, G BOISSERIE, D DORMONT, C HARDIMAN, B TEP, T FAILLOT, H DUFFAU, J SIMON. (1998) Intérêt de la radiothérapie en conditions stéréotaxiques (radiochirurgie) des métastases cérébrales: expérience et résultats du groupe hospitalier Pitié-Salpêtrière. Cancer/Radiothérapie 2:3, 272-281
CrossRef465
Kathleen R. Bell, Michael W. O'Dell, Karen Barr, Stuart A. Yablon. (1998) Rehabilitation of the patient with brain tumor. Archives of Physical Medicine and Rehabilitation 79:3, S37-S46
CrossRef466
Jennifer Dunn Bucholtz. (1998) Central nervous system metastases. Seminars in Oncology Nursing 14:1, 61-72
CrossRef467
John H. Sampson, James H. Carter, Allan H. Friedman, Hilliard F. Seigler. (1998) Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. Journal of Neurosurgery 88:1, 11-20
CrossRef468
Frederick F. Lang, Raymond Sawaya. (1998) Surgical treatment of metastatic brain tumors. Seminars in Surgical Oncology 14:1, 53-63
CrossRef469
Sandra S. Vermeulen. (1998) Whole brain radiotherapy in the treatment of metastatic brain tumors. Seminars in Surgical Oncology 14:1, 64-69
CrossRef470
Ronald F. Young. (1998) Radiosurgery for the treatment of brain metastases. Seminars in Surgical Oncology 14:1, 70-78
CrossRef471
FRIEDRICH M. CAVAGNA, FABIO MAGGIONI, PAOLO M. CASTELLI, MASSIMO DAPRA, LUIGI G. IMPERATORI, VITO LORUSSO, BRUCE G. JENKINS. (1997) Gadolinium Chelates with Weak Binding to Serum Proteins. INVESTIGATIVE RADIOLOGY 32:12, 780-796
CrossRef472
Daniel R. Pieper, Kenneth R. Hess, Raymond E. Sawaya. (1997) Role of surgery in the treatment of brain metastases in patients with breast cancer. Annals of Surgical Oncology 4:6, 481-490
CrossRef473
Avraham Eisbruch, Allen S. Lichter. (1997) What a surgeon needs to know about radiation. Annals of Surgical Oncology 4:6, 516-522
CrossRef474
Martin Kocher. (1997) Resektion singulärer Hirnmetastasen vor Ganzhirnbestrahlung. Strahlentherapie und Onkologie 173:8, 433-434
CrossRef475
Steven D. Heys, David Currie, Oleg Eremin. (1997) The management of patients with advanced cancer (III). European Journal of Surgical Oncology (EJSO) 23:4, 361-365
CrossRef476
Robert Dreicer, Sheila S. Galbraith, Charles S. Davis, William A. See. (1997) Surgical resection of metastatic renal cell carcinoma: The University of Iowa experience. Urologic Oncology: Seminars and Original Investigations 3:3, 99-101
CrossRef477
Kei Kawana, Hiroyuki Yoshikawa, Harushige Yokota, Takashi Onda, Keiichi Nakagawa, Osamu Tsutsumi, Yuji Taketani. (1997) Successful Treatment of Brain Metastases from Ovarian Cancer Using Gamma-Knife Radiosurgery. Gynecologic Oncology 65:2, 357-359
CrossRef478
David Hoegler. (1997) Radiotherapy for palliation of symptoms in incurable cancer. Current Problems in Cancer 21:3, 129-183
CrossRef479
G. Rees Cosgrove, Fred H. Hochberg, Nicholas T. Zervas, Francisco S. Pardo, Raul F. Valenzuela, Paul Chapman. (1997) Interstitial Irradiation of Brain Tumors, Using a Miniature Radiosurgery Device: Initial Experience. Neurosurgery 40:3, 518-525
CrossRef480
Michael Gieger, Julian K. Wu, Marilyn N. Ling, David Wazer, Jen-San Tsai, Mark J. Engler. (1997) Response of intracranial melanoma metastases to stereotactic radiosurgery. Radiation Oncology Investigations 5:2, 72-80
CrossRef481
Eduardo Fernandez-Vicioso, John H. Suh, Patrick A. Kupelian, Jason W. Sohn, Gene H. Barnett. (1997) Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery. Radiation Oncology Investigations 5:1, 31-37
CrossRef482
(1997) Surgery or Radiosurgery?. Journal of Neurosurgery 86:1,
CrossRef483
Cargill H. Alleyne, Tim H. Fox, Jeffrey J. Olson, George A. Cotsonis, Ian Crocker, Roy A.E. Bakay. (1997) Stereotactic radiosurgery of malignant and benign intracranial lesions utilizing a patient rotator. Radiation Oncology Investigations 5:1, 20-30
CrossRef484
James D Luketich, Michael E Burt. (1996) Does Resection of Adrenal Metastases From Non-Small Cell Lung Cancer Improve Survival?. The Annals of Thoracic Surgery 62:6, 1614-1616
CrossRef485
Steven K. Seung, Hui-Kuo G. Shu, Michael W. McDermott, Penny K. Sneed, David A. Larson. (1996) STEREOTACTIC RADIOSURGERY FOR MALIGNANT MELANOMA TO THE BRAIN. Surgical Clinics of North America 76:6, 1399-1411
CrossRef486
Eric S. Nussbaum, Hamid R. Djalilian, Kwan H. Cho, Walter A. Hall. (1996) Brain metastases: Histology, multiplicity, surgery, and survival. Cancer 78:8, 1781-1788
CrossRef487
Federico L. Ampil, Anil Nanda, Brian K. Willis, Indrani Nandy, Rosemary Meehan. (1996) Metastatic Disease in the Cerebellum. American Journal of Clinical Oncology 19:5, 509-511
CrossRef488
Arlan H. Mintz, John Kestle, Michel P. Rathbone, Laurie Gaspar, Herman Hugenholtz, Barbara Fisher, Graeme Duncan, Peter Skingley, Gary Foster, Mark Levine. (1996) A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78:7, 1470-1476
CrossRef489
Maarouf A. Hammound, Ian E. McCutcheon, Rabih Elsouki, Derek Schoppa, Yehuda Z. Patt. (1996) Colorectal carcinoma and brain metastasis: Distribution, treatment, and survival. Annals of Surgical Oncology 3:5, 453-463
CrossRef490
Flemming Bach, Jens B. Sørensen, Lene Adrian, Henrik Larsen, Seppo W. Langer, Knud M. Nelausen, Svend A. Engelholm. (1996) Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regimens of therapeutic brain irradiation. Lung Cancer 15:2, 171-181
CrossRef491
Alfredo Mussi, Massimo Pistolesi, Marco Lucchi, Alberto Janni, Antonio Chella, Giovanni Parenti, Giuseppe Rossi, Carlo Alberto Angeletti. (1996) Resection of single brain metastasis in non-small-cell lung cancer: Prognostic factors. The Journal of Thoracic and Cardiovascular Surgery 112:1, 146-153
CrossRef492
Melvyn Goldberg. (1996) 4. Surgical approaches in special situations. Current Problems in Cancer 20:3, 179-196
CrossRef493
Tord D. Alden, John W. Gianino, Theodore J. Saclarides. (1996) Brain metastases from colorectal cancer. Diseases of the Colon & Rectum 39:5, 541-545
CrossRef494
Ajay K. Bindal, Rajesh K. Bindal, Kenneth R. Hess, Almon Shiu, Samuel J. Hassenbusch, Wei Ming Shi, Raymond Sawaya. (1996) Surgery versus radiosurgery in the treatment of brain metastasis. Journal of Neurosurgery 84:5, 748-754
CrossRef495
Akio Takamura, Hiroki Shirato, Hiroya Saito, Yasuo Sakurai. (1996) Factors associated with tumor response and survival in radiosurgery for brain metastasis. International Journal of Clinical Oncology 1:1, 23-30
CrossRef496
M SALVATI, L CERVONI, R CARUSO, F GAGLIARDI. (1996) Solitary cerebral metastasis from melanoma: value of the ‘en bloc’ resection. Clinical Neurology and Neurosurgery 98:1, 12-14
CrossRef497
Gabriele Schackert. (1996) Resection of brain metastases. European Surgery 28:1, 18-23
CrossRef498
Henric Blomgren. (1996) Brain Tumors. Acta Oncologica 35:s7, 16-21
CrossRef499
Friedrich Weber, Andreas Riedel, Winfried K
CrossRef500
Roy A. Patchell. (1996) The Treatment of Brain Metastases. Cancer Investigation 14:2, 169-177
CrossRef501
Carl Johan Fürst. (1996) Quality of Life. Acta Oncologica 35:s7, 141-148
CrossRef502
Zbigniew Petrovich, Gary Luxton, Silvia Formenti, Gabor Jozsef, Chi-Shing Zee, Michael L. J. Apuzzo. (1996) Stereotactic Radiosurgery for Primary and Metastatic Brain Tumors. Cancer Investigation 14:5, 445-454
CrossRef503
Robert G. Parker. (1996) Palliative Use of Ionizing Radiations. Acta Oncologica 35:8, 981-987
CrossRef504
James D. Luketich, Nael Martini, Robert J. Ginsberg, David Rigberg, Michael E. Burt. (1995) Successful treatment of solitary extracranial metastases from non—small cell lung cancer. The Annals of Thoracic Surgery 60:6, 1609-1611
CrossRef505
Marek Wroński, Ehud Arbit, Michael Burt, Joseph H. Galicich. (1995) Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. Journal of Neurosurgery 83:4, 605-616
CrossRef506
Rajesh K. Bindal, Raymond Sawaya, Milam E. Leavens, Kenneth R. Hess, Sarah H. Taylor. (1995) Reoperation for recurrent metastatic brain tumors. Journal of Neurosurgery 83:4, 600-604
CrossRef507
Minesh P. Mehta. (1995) The physical, biologic, and clinical basis of radiosurgery. Current Problems in Cancer 19:5, 270-328
CrossRef508
Peter A. Forsyth, Patrick J. Kelly, Terrence L. Cascino, Bernd W. Scheithauer, Edward G. Shaw, Robert P. Dinapoli, Elizabeth J. Atkinson. (1995) Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?. Journal of Neurosurgery 82:3, 436-444
CrossRef509
R Abratt. (1995) Resection of a solitary brain metastasis in a patient with small cell lung cancer—Long-term survival. European Journal of Cancer 31:3, 419
CrossRef510
Gene H. Barnett, Charles P. Steiner, Joseph Weisenberger. (1995) Intracranial Meningioma Resection Using Frameless Stereotaxy. Computer Aided Surgery 1:1, 46-52
CrossRef511
T. P. L. Roberts, H. A. Rowley, E. Zusman, M. McDermott, N. Barbaro. (1995) Brief Clinical Report:Correlation of Functional Magnetic Source Imaging with Intraoperative Cortical Stimulation in Neurosurgical Patients. Computer Aided Surgery 1:6, 339-347
CrossRef512
Ken Kodama, Osamu Doi, Masahiko Higashiyama, Hideoki Yokouchi, Hidemitsu Nakagawa, Yoichi Mori. (1994) Surgery for brain metastases from nonsmall cell lung carcinomas and tissue cultures from the resected specimens. Journal of Surgical Oncology 57:2, 121-128
CrossRef513
Arthur Gerl, Christoph Clemm, Peter Kohl, Andreas Schalhorn, Wolfgang Wilmanns. (1994) Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer. Clinical & Experimental Metastasis 12:3, 226-230
CrossRef514
F.Hammond Cole, James E. Thomas, A.Brian Wilcox, Hollis H. Halford. (1994) Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: Is it worthwhile?. The Annals of Thoracic Surgery 57:4, 838-840
CrossRef515
David G. Payne. (1994) The role of radiation oncology in small cell lung cancer. Critical Reviews in Oncology/Hematology 16:2, 113-127
CrossRef516
(1994) Case 43-1993: Occipital Mass. New England Journal of Medicine 330:11, 793-793
Full Text517
(1994) Clinical Problem-Solving: The Pursuit of Certainty. New England Journal of Medicine 330:9, 644-645
Full Text518
Raymond Sawaya, B. Lee Ligon, Rajesh K. Bindal. (1994) Management of metastatic brain tumors. Annals of Surgical Oncology 1:2, 169-178
CrossRef519
Kenneth W. Culver, John Van Gilder, Charles J. Link, Thomas Carlstrom, Thomas Buroker, William Yuh, Kevin Koch, Kay Schabold, Shirley Doombas, Brenda Wetjen. (1994) Gene Therapy for the Treatment of Malignant Brain Tumors with In Vivo Tumor Transduction with the Herpes Simplex Thymidine Kinase Gene/Ganciclovir System. Iowa Methodist Medical Center, Des Moines, Iowa. Human Gene Therapy 5:3, 343-379
CrossRef520
Douglas W. Laske, Orhan Ilercil, Aytac Akbasak, Richard J. Youle, Edward H. Oldfield. (1994) Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. Journal of Neurosurgery 80:3, 520-526
CrossRef521
Lisa M. DeAngelis. (1994) Management of Brain Metastases. Cancer Investigation 12:2, 156-165
CrossRef522
C. Nieder, M. Niewald, K. Schnabel, W. Berberich. (1994) Value of surgery and radiotherapy in the treatment of brain metastases. Radiation Oncology Investigations 2:1, 50-55
CrossRef523
Mitchell H. Katz, Walter W. Hauck. (1993) Proportional hazards (Cox) regression. Journal of General Internal Medicine 8:12, 702-711
CrossRef524
V. Valentino, M. A. Mirri, G. Schinaia, G. Ore. (1993) Linear accelerator and Greitz-Bergstrom's head fixation system in radiosurgery of single cerebral metastases. A report of 86 cases. Acta Neurochirurgica 121:3-4, 140-145
CrossRef525
Leonard H. Wexler, Thomas F. Delaney, Stephen Saris, Marc E. Horowitz. (1993) Long-term survival after central nervous system relapse in a patient with osteosarcoma. Cancer 72:4, 1203-1208
CrossRef526
Rajesh K. Bindal, Raymond Sawaya, Milam E. Leavens, J. Jack Lee. (1993) Surgical treatment of multiple brain metastases. Journal of Neurosurgery 79:2, 210-216
CrossRef527
Charles J. Vecht, Hanny Haaxma-Reiche, Evert M. Noordijk, George W. Padberg, Joan H. C. Voormolen, Foppe H. Hoekstra, Joseph Th. J. Tans, Nanno Lambooij, Jan A. L. Metsaars, A. Rolf Wattendorff, Ronald Brand, Jo Hermans. (1993) Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery. Annals of Neurology 33:6, 583-590
CrossRef528
J.Douglas Miller. (1993) NEUROSURGERY. The Lancet 341:8860, 1566
CrossRef529
E. A. Popovic, G. C. A. Fabinyi, G. A. Brazenor, F. Daniel, C. P. Clarke. (1993) CRANIOTOMY AND THORACOTOMY FOR NON-SMALL CELL CARCINOMA OF THE LUNG WITH CEREBRAL METASTASIS. ANZ Journal of Surgery 63:5, 341-345
CrossRef530
Barry E. Epstein, Charles B. Scott, William T. Sause, Marvin Rotman, Penny K. Sneed, Nora A. Janjan, Lawrence W. Davis, Hosny Selim, Mohammed Mohiuddin, Todd H. Wasserman, Walter J. Curran. (1993) Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater results of radiation therapy oncology group 85–28. Cancer 71:4, 1362-1367
CrossRef531
Rita Engenhart, Bernhard N. Kimmig, Karl-Heinz Höver, Bernd Wowra, Jürgen Romahn, Walter J. Lorenz, Gerhard Van Kaick, Michael Wannenmacher. (1993) Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71:4, 1353-1361
CrossRef532
Carlos A. Perez, Dennis Cosmatos, Delia M. Garcia, Avraham Eisbruch, Colin A. Poulter. (1993) Irradiation in relapsing carcinoma of the prostate. Cancer 71:S3, 1110-1122
CrossRef533
L. C. Barr, A. I. Skene, J. Meirion Thomas. (1992) Metastasectomy. British Journal of Surgery 79:12, 1268-1274
CrossRef534
Marek Wronski, Michael Burt, Paolo Macchiarini, C. Alberto Angeletti. (1992) Results and prognostic factors of surgery in the management of non-small cell lung cancer with solitary brain metastasis. Cancer 70:7, 2021-2023
CrossRef535
Stephen R. Smalley, Edward R. Laws, Judith R. O'Fallon, Edward G. Shaw, Mark F. Schray. (1992) Resection for solitary brain metastasis. Journal of Neurosurgery 77:4, 531-540
CrossRef536
Stuart A. Grossman, Carla Reinhard, O. Michael Colvin, Mark Chasin, Robert Brundrett, Rafael J. Tamargo, Henry Brem. (1992) The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. Journal of Neurosurgery 76:4, 640-647
CrossRef537
John R. Adler, Richard S. Cox, Irving Kaplan, David P. Martin. (1992) Stereotactic radiosurgical treatment of brain metastases. Journal of Neurosurgery 76:3, 444-449
CrossRef538
Wayne T. Spears, James G. Morphis, Steven G. Lester, Stephen D. Williams, Lawrence H. Einhorn. (1992) Brain metastases and testicular tumors: Long-term survival. International Journal of Radiation Oncology*Biology*Physics 22:1, 17-22
CrossRef539
Russell Scott Anderson, Anas M. El Mahdi, Deborah A. Kuban, Elizabeth M. Higgins. (1992) Brain metastases from transitional cell carcinoma of urinary bladder. Urology 39:1, 17-20
CrossRef540
Val M. Runge, John E. Kirsch, Vickie J. Burke, Ann C. Price, Kevin L. Nelson, Greg S. Thomas, Bruce L. Dean, Charles Lee. (1992) High-dose gadoteridol in MR imaging of intracranial neoplasms. Journal of Magnetic Resonance Imaging 2:1, 9-18
CrossRef541
H. Thomas, H.E. Lambert. (1992) Solitary cerebral metastases from gynaecological malignancy: The case for radical therapy. Clinical Oncology 4:2, 133-134
CrossRef542
R G BOURNE. (1991) Shades of Gray: A Personal View of Palliation by Radiotherapy*. Australasian Radiology 35:4, 374-378
CrossRef543
Michael Ashby. (1991) The role of radiotherapy in palliative care. Journal of Pain and Symptom Management 6:6, 380-388
CrossRef544
Paolo Macchiarini, Alfredo Mussi, Carlo A. Angeletti, Renato Buonaguidi, Michael Hardin. (1991) Results and prognostic factors of surgery in the management of non-small cell lung cancer with solitary brain metastasis. Cancer 68:2, 300-304
CrossRef545
Black, Peter McL., . (1991) Brain Tumors. New England Journal of Medicine 324:22, 1555-1564
Full Text546
Daniel C. Ihde, John D. Minna. (1991) Non-small cell lung cancer Part II: Treatment. Current Problems in Cancer 15:3, 109-154
CrossRef547
Peter D. Leroux, Mitchel S. Berger, J. Paul Elliott, Hisham K. Tamimi. (1991) Cerebral metastases from ovarian carcinoma. Cancer 67:8, 2194-2199
CrossRef548
(1990) Surgery for Single Brain Metastasis. New England Journal of Medicine 323:2, 132-133
Full Text549
Posner, Jerome B., . (1990) Surgery for Metastases to the Brain. New England Journal of Medicine 322:8, 544-545
Full Text
- Letters
